<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">3 Biotech</journal-id><journal-id journal-id-type="iso-abbrev">3 Biotech</journal-id><journal-title-group><journal-title>3 Biotech</journal-title></journal-title-group><issn pub-type="ppub">2190-572X</issn><issn pub-type="epub">2190-5738</issn><publisher><publisher-name>Springer Berlin Heidelberg</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4162903</article-id><article-id pub-id-type="publisher-id">180</article-id><article-id pub-id-type="doi">10.1007/s13205-013-0180-y</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Antimicrobial resistance (AMR) and plant-derived antimicrobials (PDA<sub>m</sub>s) as an alternative drug line to control infections</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Srivastava</surname><given-names>Jatin</given-names></name><address><phone>+91-9453-954065</phone><fax>0522-2351662</fax><email>jks_345@rediffmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Chandra</surname><given-names>Harish</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Nautiyal</surname><given-names>Anant R.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Kalra</surname><given-names>Swinder J. S.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label>Department of Applied Sciences, Faculty of Environmental Science, Himalayan Institute of Technology and Management, BKT, NH 24, Lucknow, 227005 UP India </aff><aff id="Aff2"><label>2</label>Department of Medicinal and Aromatic Plants, School of Agriculture and Allied Sciences, High Altitude Plant Physiology Research Center, H.N.B. Garhwal University, Srinagar, Uttrakhand India </aff><aff id="Aff3"><label>3</label>Department of Chemistry, Dayanand Anglo Vedic College, Civil Lines, Kanpur, UP India </aff></contrib-group><pub-date pub-type="epub"><day>23</day><month>10</month><year>2013</year></pub-date><pub-date pub-type="pmc-release"><day>23</day><month>10</month><year>2013</year></pub-date><pub-date pub-type="ppub"><month>10</month><year>2014</year></pub-date><volume>4</volume><issue>5</issue><fpage>451</fpage><lpage>460</lpage><history><date date-type="received"><day>1</day><month>8</month><year>2013</year></date><date date-type="accepted"><day>7</day><month>10</month><year>2013</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2013</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.</license-p></license></permissions><abstract id="Abs1"><p> Infectious diseases caused by antimicrobial-resistant microbes (ARMs) and the treatment are the serious problems in the field of medical science today world over. The development of alternative drug line to treat such infectious diseases is urgently required. Researches on ARMs revealed the presence of membrane proteins responsible for effusing the antibiotics from the bacterial cells. Such proteins have successfully been treated by plant-derived antimicrobials (PDA<sub>m</sub>s) synergistically along with the commercially available antibiotics. Such synergistic action usually inhibits the efflux pump. The enhanced activity of plant-derived antimicrobials is being researched and is considered as the future treatment strategy to cure the incurable infections. The present paper reviews the advancement made in the researches on antimicrobial resistance along with the discovery and the development of more active PDA<sub>m</sub>s.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Antimicrobial<bold>-</bold>resistant microbes</kwd><kwd>Efflux pumps</kwd><kwd>Antimicrobial resistance</kwd><kwd>Plant antimicrobial compounds</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2014</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p>Increasing antimicrobial resistance (AMR) among microbes caused the emergence of new resistant phenotypes and further caused the development of new antimicrobial compounds (Goossens <xref ref-type="bibr" rid="CR36">2013</xref>). Infectious diseases caused by antimicrobial-resistant microbes (ARM) have been frequently reported since last few years (Vila and Pal <xref ref-type="bibr" rid="CR87">2010</xref>). About 440,000 new cases of multidrug-resistant tuberculosis (MDR-TB) are recorded annually, causing approximately 150,000 deaths all over the world. Recently, a joint meeting of medical societies, the first ever in India was held to tackle the challenges of antimicrobial resistance in developing world (Ghafur <xref ref-type="bibr" rid="CR31">2013</xref>). As a result of this conference &#x0201c;Chennai declaration&#x0201d; came into existence, initiating efforts through a national policy to control the rising trend of AMR in India and abroad (Ghafur et al. <xref ref-type="bibr" rid="CR32">2012</xref>).</p><p>Multidrug-resistant (MDR) microbes are resistant to three or more antibiotics (Styers et al. <xref ref-type="bibr" rid="CR80">2006</xref>), however; strains of <italic>Mycobacterium</italic><italic>tuberculosis</italic>, resistant to virtually all classes of antimicrobials have also been identified in the Kwa Zulu Natal Province of South Africa (Gandhi et al. <xref ref-type="bibr" rid="CR30">2006</xref>), a typical example of Extremely Drug-Resistant Tuberculosis (XDR TB) reported in 64 countries to date (World Health Organization <xref ref-type="bibr" rid="CR91">2011</xref>). The global emergence of MDRs is increasingly limiting the effectivity of the existing antibiotic drugs (Hancock <xref ref-type="bibr" rid="CR38">2005</xref>) for e.g. methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA) and vancomycin-resistant <italic>Enterococci spp</italic>. (Norrby et al. <xref ref-type="bibr" rid="CR60">2005</xref>). The development of resistance among the microbes is the result of continuous selection pressure of antibiotics and their surroundings causing genetic alterations (Bush <xref ref-type="bibr" rid="CR12">2004</xref>) which, are transferred to the next generation and reach out to the wider range of other geographical regions through the transfer of genetic information exchange between microbes (Am&#x000e1;bile-Cuevas <xref ref-type="bibr" rid="CR6">2003</xref>) (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> presents the examples of some of the common MDRs). In this review, attempt has been made to understand specific issues such as factors causing resistance, the role of developing world with a quick overview of plant-derived antimicrobials (PDA<sub>m</sub>) and synergistic compounds as an alternative drug line.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Examples of plasmids carrying integron integrase carrying gene cassettes imparting resistance against antimicrobials</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Plasmid gene cassette</th><th align="left">Resistance against</th><th align="left">Microbes (isolation)</th><th align="left">Conjugative transfer</th><th align="left">References</th></tr></thead><tbody><tr><td align="left">
<italic>pVN84</italic>
</td><td align="left">MDR</td><td align="left"><italic>Vibrio</italic> spp.</td><td align="left">&#x02713;</td><td align="left">Rajpara et al. (<xref ref-type="bibr" rid="CR68">2009</xref>)</td></tr><tr><td align="left"><italic>MLS</italic><sub><italic>B</italic></sub> [<italic>erm</italic>(<italic>B</italic>) &#x00026; <italic>erm</italic>(<italic>C</italic>)]</td><td align="left">Erythromycin</td><td align="left"><italic>Staphylococcus</italic> spp.</td><td align="left">&#x02718;</td><td align="left">Schlegelova et al. (<xref ref-type="bibr" rid="CR75">2008</xref>)</td></tr><tr><td align="left"><italic>grlA</italic> or <italic>gyr A</italic></td><td align="left">Ciprofloxacin</td><td align="left"><italic>Staphylococcus</italic> spp.</td><td align="left">&#x02718;</td><td align="left">Campion et al. (<xref ref-type="bibr" rid="CR16">2004</xref>)</td></tr><tr><td align="left">
<italic>pbp2X</italic>
</td><td align="left">&#x003b2;-Lactam</td><td align="left"><italic>Staphylococcus</italic> spp.</td><td align="left">&#x02718;</td><td align="left">Coffey et al. (<xref ref-type="bibr" rid="CR20">1991</xref>)</td></tr><tr><td align="left" colspan="5"><italic>CTX</italic>-<italic>M</italic></td></tr><tr><td align="left">&#x000a0;<italic>aac</italic>(<italic>6</italic>&#x02032;)-Ib</td><td align="left">Aminoglycoside</td><td align="left">
<italic>Klebsiella pneumoniae</italic>
</td><td align="left">&#x02713;</td><td align="left" rowspan="4">Soge et al. (<xref ref-type="bibr" rid="CR77">2006</xref>)</td></tr><tr><td align="left">&#x000a0;<italic>emr</italic>(B)</td><td align="left">Macrolide-lincosamide-streptogramin B</td><td align="left">
<italic>K. pneumoniae</italic>
</td><td align="left">&#x02713;</td></tr><tr><td align="left">&#x000a0;<italic>pla</italic> TEM-1</td><td align="left">Ampicillin</td><td align="left">
<italic>K. pneumoniae</italic>
</td><td align="left">&#x02713;</td></tr><tr><td align="left">&#x000a0;<italic>dfr</italic></td><td align="left">Trimethoprim</td><td align="left">
<italic>K. pneumoniae</italic>
</td><td align="left">&#x02713;</td></tr><tr><td align="left" colspan="5">
<italic>p3iANG</italic>
</td></tr><tr><td align="left">&#x000a0;<italic>dfr</italic>A15</td><td align="left">Trimathoprim</td><td align="left">
<italic>Vibrio cholerae</italic>
</td><td align="left">&#x02713;</td><td align="left" rowspan="4">Ceccarelli et al. (<xref ref-type="bibr" rid="CR17">2006</xref>)</td></tr><tr><td align="left">&#x000a0;<italic>bla</italic> PI</td><td align="left">&#x003b2;-Lactam</td><td align="left">
<italic>V. cholerae</italic>
</td><td align="left">&#x02713;</td></tr><tr><td align="left">&#x000a0;<italic>qacH</italic></td><td align="left">Quaternary ammonia-compounds</td><td align="left">
<italic>V. cholerae</italic>
</td><td align="left">&#x02713;</td></tr><tr><td align="left">&#x000a0;<italic>aadA8</italic></td><td align="left">aminoglycosides</td><td align="left">
<italic>V. cholerae</italic>
</td><td align="left">&#x02713;</td></tr><tr><td align="left">
<italic>mecA</italic>
</td><td align="left">Methicillin (MDR)</td><td align="left">
<italic>S. aureus</italic>
</td><td align="left">&#x02718;</td><td align="left">Hiramatsu et al. (<xref ref-type="bibr" rid="CR39">2002</xref>)</td></tr><tr><td align="left"><italic>qnr</italic> (carried on class 1 integron)</td><td align="left">Ciprofloxacin</td><td align="left">
<italic>V. Cholerae</italic>
</td><td align="left">&#x02718;</td><td align="left">Fonseca et al. (<xref ref-type="bibr" rid="CR29">2008</xref>)</td></tr><tr><td align="left">
<italic>bla</italic>
<sub><italic>MDL</italic>-<italic>1</italic></sub>
</td><td align="left">Carbapenem</td><td align="left">
<italic>Enterobacteriaceae</italic>
</td><td align="left">&#x02713;</td><td align="left">Kumarasamy et al. (<xref ref-type="bibr" rid="CR50">2010</xref>)</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec2"><title>Factors causing AMR</title><p>Microbes comprise 50&#x000a0;% of total living biomass and are well-survived life forms on earth. There exists a sharp distinction between microbes as pathogenic and non-pathogenic although; one-way exchange of genetic elements (Am&#x000e1;bile-Cuevas <xref ref-type="bibr" rid="CR6">2003</xref>) may confer the pathogenic characters to the non-pathogenic microbe. Pathogenic microbes cause infectious diseases in humans and animals and are treated with antibiotics. Antibiotics also known as antimicrobials are chemical substances, toxic for most of the life forms. Irrational and deliberate use of antibiotics, migration of infected individuals to other communities (Memish et al. <xref ref-type="bibr" rid="CR58">2003</xref>), prolonged use of medical health care systems in hospitals, hunger and malnutrition are some of the main causes of the development of resistance against antibiotics in the microbes (Byarugaba <xref ref-type="bibr" rid="CR14">2004</xref>; Vila and Pal <xref ref-type="bibr" rid="CR87">2010</xref>). Antimicrobial use in veterinary practices especially as food additives is one of the causes of development of AMRs in zoonotics that may spread to humans (Memish et al. <xref ref-type="bibr" rid="CR58">2003</xref>) through the food chain. In this connection, reports of Schlegelova et al. (<xref ref-type="bibr" rid="CR75">2008</xref>) suggest, least chances of spreading of a resistant strain through the dairy products, however; improperly processed raw meat is strongly discouraged for human consumption in developed nations (Threlfall <xref ref-type="bibr" rid="CR85">2002</xref>).</p><sec id="Sec3"><title>Molecular understanding of AMR</title><p>Microbes attain resistance very rapidly against most of the currently available antibiotics because of the adaptability feature conferred by plasmids. Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> presents the examples of such plasmids carrying integron and gene cassettes in most common MDRs which on transfer, widespread the resistance (Kumarasamy et al. <xref ref-type="bibr" rid="CR50">2010</xref>). Gram-negative (Kumarasamy et al. <xref ref-type="bibr" rid="CR50">2010</xref>) and Gram-positive bacteria (Grohman et al. <xref ref-type="bibr" rid="CR37">2003</xref>) both exhibit conjugative transfer of plasmids, a natural way of horizontal gene transfer for e.g. the horizontal transfer of plasmid in between <italic>Vibrio fluvialis</italic> and <italic>Vibrio cholerae</italic> conferring resistance to <italic>V. fluvialis</italic> (Rajpara et al. <xref ref-type="bibr" rid="CR68">2009</xref>). Recent cases of AMR development include <italic>Pseudomonas</italic><italic>aeruginosa</italic> and <italic>Acinetobacter</italic><italic>baumannii</italic> resistant to nearly all antibiotics including the carbanems (Huang and Hsueh <xref ref-type="bibr" rid="CR41">2008</xref>). Antibiotic inactivation (degradation of antibiotics by the microbial enzymes e.g. transferase and &#x003b2;-lactamase) causes resistance in microbes (Wright <xref ref-type="bibr" rid="CR93">2005</xref>; Jacoby and Munoz-Price <xref ref-type="bibr" rid="CR44">2005</xref>), more than 1,000 such &#x003b2;-lactamases are identified till date (Bush and Fisher <xref ref-type="bibr" rid="CR13">2011</xref>). Different antibiotics have different mode of actions, therefore, their use is largely dependent on variety of traits other than resistance (Am&#x000e1;bile-Cuevas <xref ref-type="bibr" rid="CR7">2010</xref>) which either undergo rapid enzymatic degradation or actively effused by the resistant bacteria. Efflux pump in MDRs was first described by Roberts (<xref ref-type="bibr" rid="CR72">1996</xref>) for tetracycline and macrolide antibiotics. In general, efflux pumps act through membrane proteins of substrate specificity, effuse the antibiotics from the bacterial cell, resulting in a low intracellular ineffective concentration of the drug (Gibbons <xref ref-type="bibr" rid="CR33">2004</xref>; Thorrold et al. <xref ref-type="bibr" rid="CR84">2007</xref>) altering the permeability of membrane. In a study, staphylococcal accessory regulator (<italic>sarA</italic>) was reported to contribute promising role, imparting resistance in <italic>S. aureus</italic> (Riordan et al. <xref ref-type="bibr" rid="CR71">2006</xref>). In addition, Kuete et al. (<xref ref-type="bibr" rid="CR49">2011</xref>) reported two efflux pumps viz., AcerAB-TolC (Enterobacteriaceae) and MexAB-OprM (<italic>Pseudomonas</italic><italic>aeruginosa</italic>) imparting resistance in Gram-negative bacteria against natural products. AMR is a genetically-modified manifestation, linked to the point mutation in bacterial non-chromosomal DNA. As in case of MRSA, the resistance to methicillin is associated with acquisition of a mobile genetic element, <italic>SCCmec</italic>, which contains <italic>mecA-</italic>resistant gene (Okuma et al. <xref ref-type="bibr" rid="CR63">2002</xref>). Analytical procedure followed on <italic>Escherichia coli</italic> showed reversible function of class 1 integron integrase gene machinery under selective pressure (D&#x000ed;az-Mej&#x000ed;a et al. <xref ref-type="bibr" rid="CR24">2008</xref>). Similar results were also observed by Hsu et al. (<xref ref-type="bibr" rid="CR40">2006</xref>) whereby <italic>E</italic>. <italic>coli</italic> MDR was found associated with the class 1 integron gene. Detailed mechanism of development of AMR among microbes has been extensively reviewed by Byarugaba (<xref ref-type="bibr" rid="CR15">2010</xref>).</p></sec></sec><sec id="Sec4"><title>Developing world: the factory of MDRs</title><p>Developing world especially the countries of South East Asia, Western and Central Africa, India and Pakistan are the most vulnerable for various infectious pandemic diseases. Byarugaba (<xref ref-type="bibr" rid="CR14">2004</xref>) comprehensively reviewed and reported the AMR in developing countries. Several factors are associated with the AMR development including nosocomial infections, unsafe disposal of biomedical waste, inappropriately used antibiotics, self drug abuse, shortfall of antibiotic course and lack of mass awareness of infectious diseases and personal hygiene (Okeke et al. <xref ref-type="bibr" rid="CR61">2005a</xref>, <xref ref-type="bibr" rid="CR62">b</xref>). In addition to these, lack of surveillance data, providing information of microbial infections common to a geographic location and the invasive microbial species have been suggested as the major causes of MDRs development in developing countries (Okeke et al. <xref ref-type="bibr" rid="CR61">2005a</xref>, <xref ref-type="bibr" rid="CR62">b</xref>; Giske and Cornaglia <xref ref-type="bibr" rid="CR34">2010</xref>; Kartikeyan et al. <xref ref-type="bibr" rid="CR47">2010</xref>; Lalitha et al. <xref ref-type="bibr" rid="CR51">2013</xref>). Giske and Cornaglia (<xref ref-type="bibr" rid="CR34">2010</xref>) emphasized on the surveillance practices especially the monitoring and sampling techniques of invasive microbial isolates. Surveillance of resistance in many developing countries is suboptimal (Okeke et al. <xref ref-type="bibr" rid="CR62">2005b</xref>) and unable to present the real picture of infectious diseases and the medication. Recent reports of Lalitha et al. (<xref ref-type="bibr" rid="CR51">2013</xref>) showed the feasibility of proper surveillance of resistance by carrying experimental surveillance study on the school children in different geographic locations of Indian subcontinent. In India for <italic>Salmonella</italic><italic>typhi</italic>, MDR has become a norm in strains. This widespread resistant bacterium is associated with contaminated water supply in developing countries and through food products such as contaminated meat in developed countries (Threlfall <xref ref-type="bibr" rid="CR85">2002</xref>). Remarkable report of Kumarasamy et al. (<xref ref-type="bibr" rid="CR50">2010</xref>) provides sufficient evidences in support of the positive role of developing world in the development of ARMs. Resistance to carbapenem conferred by plasmid encoded New Delhi metallo-&#x003b2;-lactamase-1 (<italic>bla</italic><sub><italic>NDM</italic>-1</sub>) is a worldwide health problem, especially in UK, (Kumarasamy et al. <xref ref-type="bibr" rid="CR50">2010</xref>) having the roots in India and Pakistan. The selective pressure on the bacterial cells is associated with the adaptations causing resistance among microbes for multiple antimicrobials for e.g. genes encoding NDM-1, OXA-23 and OXA-51 enzymes (hydrolyzing specific antibiotics) were observed in three different isolates of <italic>Acinetobacter baumannii</italic> in India (Kartikeyan et al. <xref ref-type="bibr" rid="CR47">2010</xref>). Alterations in gene structure were reported in <italic>A. baumannii</italic> as a result of selection pressure of antibiotics (Kartikeyan et al. <xref ref-type="bibr" rid="CR47">2010</xref>). The literature suggest, substandard surveillance of resistance, non-prescribed antibiotic usage causes huge selection pressure resulting in the development of AMR in developing countries and their suburbs (Byarugaba <xref ref-type="bibr" rid="CR14">2004</xref>; Okeke et al. <xref ref-type="bibr" rid="CR62">2005b</xref>; Kumarasamy et al. <xref ref-type="bibr" rid="CR50">2010</xref>). Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> shows a schematic diagram showing the development of MDR microbe in community.<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Illustrative sketch of the development of MDR microbes. The sketch is divided into various segments: (<italic>1</italic>) Bacterial infection was treated with calculated amount of antimicrobial drug (X) followed by complete cure, in the same time prolonged use of drug (X) put selective pressure causing point mutation (D). (<italic>2</italic>) Second infection (in a community only) was treated with same drug (X) with a higher dose, a delayed response was displayed because of mutant bacterial strain, (<italic>3</italic>) Third time infection (in a community only) trigger the resistance, in particular microbe for a particular drug (X); therefore, synergistic compounds (Y) were administered along with (X) may be for clinical trials, the successful treatment, leading to the production of new antimicrobial drug (Z), (<italic>4</italic>) Since the earlier bacteria attained resistance in due course of time for the drug (X) transferred the resistant gene into another strain of same species of bacteria resistant to the drug (Z) which was introduced in this community from the other one, gene cassettes got recombined on the plasmid to confer multi-drug resistant status to the new introduced bacteria. Infection caused by both these bacteria might be having same symptoms which would be treated with the newly developed drug (Z) keeping the resistance against (X) in consideration. (<italic>5</italic>) Infection could not be cured because the drug was applied to cure the (X) drug-resistant bacteria however; another bacteria having resistance against (Z) remained as such</p></caption><graphic xlink:href="13205_2013_180_Fig1_HTML" id="d29e1012"/></fig></p></sec><sec id="Sec5"><title>Plants derived antimicrobial (PDA<sub>m</sub>): a ray of hope</title><p> Antimicrobial resistance is rapidly increasing along with the development of classical antibiotics consequently, there is an urgent need to develop a different drug line to treat and control MDR bacterial infections. Medicinal values of plants were known to earlier traditional medical practitioners (Emeka et al. <xref ref-type="bibr" rid="CR28">2012</xref>). PDA<sub>m</sub> substances are plant-originated secondary metabolites and have great concern because of their antibiotic activity without conferring resistance (Baris et al. <xref ref-type="bibr" rid="CR9">2006</xref>; Palaniappan and Holley <xref ref-type="bibr" rid="CR65">2010</xref>). PDA<sub>m</sub>s are classified as antimicrobial on the basis of dose ranging from 100 to 1,000&#x000a0;&#x003bc;g&#x000a0;ml<sup>&#x02212;1</sup> for the minimum inhibitory concentration (MIC) susceptibility test performed on bacteria (Tegos et al. <xref ref-type="bibr" rid="CR81">2002</xref>). Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref> presents few of the examples of plants and their active antimicrobial compounds. Plants have unlimited ability to produce wide variety of secondary metabolites most of which are aromatic compounds including alkaloids, glycosides, terpenoids, saponins, steroids, flavonoids, tannins, quinones and coumarins (Das et al. <xref ref-type="bibr" rid="CR22">2010</xref>) forming the basis of PDA<sub>m</sub> compounds (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). Target specific plant&#x02019;s secondary metabolites having potential to treat and control the infections are being screened out globally for e.g. Coumarins having specificity on <italic>Staphylococcus aureus</italic> and ineffective on Gram-negative bacteria (Lewis and Ausubel <xref ref-type="bibr" rid="CR53">2006</xref>). The literature such as Cowan (<xref ref-type="bibr" rid="CR21">1999</xref>); Lewis and Ausubel (<xref ref-type="bibr" rid="CR53">2006</xref>) and Gonz&#x000e1;lez-Lomothe et al. (<xref ref-type="bibr" rid="CR35">2009</xref>) provides comprehensive information on the major secondary metabolites of plant origin. Precise mechanistic approach of PDA<sub>m</sub> and their activity on microbes has been discussed by Lewis and Ausubel (<xref ref-type="bibr" rid="CR53">2006</xref>). In general, PDA<sub>m</sub>s (mostly secondary metabolites) are phenol derivatives, sufficiently able to control microbes by reducing pH, increasing membrane permeability, altering efflux pumping. Examples mentioned in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref> followed by recent studies of (Machado et al. <xref ref-type="bibr" rid="CR56">2003</xref>; Ram et al. <xref ref-type="bibr" rid="CR69">2004</xref>; McGaw et al. <xref ref-type="bibr" rid="CR57">2008</xref>; Renisheya et al. <xref ref-type="bibr" rid="CR70">2011</xref>; Ahmed et al. <xref ref-type="bibr" rid="CR3">2012</xref>; Emeka et al. <xref ref-type="bibr" rid="CR28">2012</xref>; Upadhyaya <xref ref-type="bibr" rid="CR86">2013</xref>) and the references there in, suggest the antimicrobial potential of various local and exotic plant species, although very few reports have suggested the mechanism of their actions. The affectivity of PDA<sub>m</sub>s largely depends upon the extraction methods (Das et al. <xref ref-type="bibr" rid="CR22">2010</xref>). In a study carried out by our group, methanolic, ethanolic and water extracts of several plants species viz., <italic>Argemone maxicana</italic>, <italic>Callistomon lanceolatus</italic>, <italic>Allium sativum</italic>, <italic>Swietenia mahogany</italic>, <italic>Citrulus colocynthis</italic>, <italic>Salvadora persica</italic>, <italic>Madhuca Indica</italic>, <italic>Acacia nilotica</italic> and <italic>Pongamia pinnata</italic> were assayed for their antimicrobial activity on most of the common MDRs viz., <italic>Staphylococcus aureus</italic>, <italic>Bacillus cereus</italic>, <italic>B. pumilus</italic>, <italic>Klebsiella pneumonia</italic>, <italic>Salmonella typhi</italic>, <italic>E. coli</italic> exhibiting activity of all the extracts, however; the target specificity of plant extracts could not be established because of uncertain mechanism of plant-derived antimicrobial compounds. A generalized mechanism of PDA<sub>m</sub>s on microbes suggests the effects of efflux pumping on MDRs: increasing permeability and reduce selection pressure (Lewis and Ausubel <xref ref-type="bibr" rid="CR53">2006</xref>). Antimicrobial peptides (AMPs) are also produced by plants against the infections also called as defensins. Plant defensins are small basic peptides, having characteristic 3D folding pattern, stabilized by eight disulfide linked cysteines (Thomma et al. <xref ref-type="bibr" rid="CR83">2002</xref>). AMPs have antimicrobial properties too (Li et al. <xref ref-type="bibr" rid="CR54">2012</xref>) and have been suggested as an alternative approach to improve treatment outcome (Brouwer et al. <xref ref-type="bibr" rid="CR11">2011</xref>), for e.g. IbAMP1, a plant originated disulfide linked &#x003b2;-sheet antimicrobial peptide (Wang et al. <xref ref-type="bibr" rid="CR89">2009</xref>).<table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Plant derivatives as antimicrobial for the treatment of microbial infections</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Plants</th><th align="left">Plant derivatives</th><th align="left">Effective against</th><th align="left">References</th></tr></thead><tbody><tr><td align="left">
<italic>Medicago sativa</italic>
</td><td align="left">Saponins, canavanine</td><td align="left">
<italic>Enterococcus faecium Staphylococcus aureus</italic>
</td><td align="left">Aliahmadi et al. (<xref ref-type="bibr" rid="CR4">2012</xref>)</td></tr><tr><td align="left">
<italic>Onobrychis sativa</italic>
</td><td align="left">AMPs (antimicrobial peptides)</td><td align="left"><italic>E. faecium</italic>, <italic>S. aureus</italic></td><td align="left">Aliahmadi et al. (<xref ref-type="bibr" rid="CR4">2012</xref>)</td></tr><tr><td align="left">
<italic>Allium sativum</italic>
</td><td align="left">Organosulfur compounds (phenolic compounds)</td><td align="left">
<italic>Campylobacter jejuni</italic>
</td><td align="left">Lu et al. (<xref ref-type="bibr" rid="CR55">2011</xref>)</td></tr><tr><td align="left">
<italic>Raphanus sativum</italic>
</td><td align="left">RsAFP2 (Antifungal peptide)</td><td align="left">
<italic>Candida albicans</italic>
</td><td align="left">Aerts et al. (<xref ref-type="bibr" rid="CR2">2009</xref>)</td></tr><tr><td align="left"><italic>Vetiveria zizanioides</italic> L. Nash</td><td align="left">Vetivone (vetiver oil)</td><td align="left"><italic>Enterobacter</italic> spp.</td><td align="left">Srivastava et al. (<xref ref-type="bibr" rid="CR78">2007</xref>)</td></tr><tr><td align="left">
<italic>Chelidonium majus</italic>
</td><td align="left">Glycoprotein</td><td align="left"><italic>B. cereus</italic>, <italic>Staphylococcus</italic> spp.</td><td align="left">Janovska et al. (<xref ref-type="bibr" rid="CR45">2003</xref>)</td></tr><tr><td align="left">
<italic>Sanguisorba officinalis</italic>
</td><td align="left">Alkaloids, antimicrobial peptides</td><td align="left"><italic>Ps. aeruginosa</italic>, <italic>E. coli</italic></td><td align="left">Janovska et al. (<xref ref-type="bibr" rid="CR45">2003</xref>)</td></tr><tr><td align="left">
<italic>Cinnamomum osmophloeum</italic>
</td><td align="left">Cinnamaldehyde (in essential oil)</td><td align="left">
<italic>Legionella pneumophila</italic>
</td><td align="left">Chang et al. (<xref ref-type="bibr" rid="CR18">2008</xref>)</td></tr><tr><td align="left">
<italic>Ocimum basilicum</italic>
</td><td align="left">Essential oil</td><td align="left">
<italic>Salmonella typhi</italic>
</td><td align="left">Wan et al. (<xref ref-type="bibr" rid="CR88">1998</xref>)</td></tr><tr><td align="left">
<italic>Micromeria nervosa</italic>
</td><td align="left">Ethanolic extract</td><td align="left">
<italic>Proteus vulgaris</italic>
</td><td align="left">Ali-Shtayeh et al. (<xref ref-type="bibr" rid="CR5">1997</xref>)</td></tr><tr><td align="left">
<italic>Rabdosia trichocarpa</italic>
</td><td align="left">Trichorabdal A</td><td align="left">
<italic>Helicobacter pylori</italic>
</td><td align="left">Kadota et al. (<xref ref-type="bibr" rid="CR46">1997</xref>)</td></tr><tr><td align="left"><italic>Melaleuca alternifolia</italic> and <italic>Eucalyptus</italic> sp.</td><td align="left">Essential oil</td><td align="left"><italic>Staphylococcus</italic> spp. and <italic>Streptococcus</italic> spp.</td><td align="left">Warnke et al. (<xref ref-type="bibr" rid="CR90">2009</xref>)</td></tr><tr><td align="left"><italic>Anthrocephalous cadamba</italic> and <italic>Pterocarpus santalinus</italic></td><td align="left">Ethanolic extract</td><td align="left">MDRs<sup>M</sup></td><td align="left">Dubey et al. (<xref ref-type="bibr" rid="CR26">2012</xref>)</td></tr><tr><td align="left"><italic>Lantana camara</italic> L.</td><td align="left">Leaf extract in dichloromethane &#x00026; methanol</td><td align="left">MDRsG&#x000a0;+&#x000a0;ve and MDRsG&#x02212;ve</td><td align="left">Dubey and Padhy (<xref ref-type="bibr" rid="CR25">2013</xref>)</td></tr><tr><td align="left"><italic>Butea monosperma</italic> Lam.</td><td align="left">Ethanolic and hot water extract of leaf</td><td align="left">MDRs<sup>M</sup></td><td align="left">Sahu and Padhy (<xref ref-type="bibr" rid="CR73">2013</xref>)</td></tr><tr><td align="left"><italic>Jatropha curcas</italic> (Linn.)</td><td align="left">Ethanolic and methanolic extract</td><td align="left">MDRsG&#x000a0;+&#x000a0;ve&#x000a0;+&#x000a0;<italic>Micrococcus</italic> sp. &#x00026; MDRsG&#x02212;ve&#x000a0;+&#x000a0;<italic>Shigella</italic> sp.&#x000a0;+&#x000a0;<italic>Bacillus</italic> sp.</td><td align="left">Igbinosa et al. (<xref ref-type="bibr" rid="CR42">2009</xref>)</td></tr><tr><td align="left"><italic>Ficus exasperate</italic> and <italic>Nauclea latifolia</italic></td><td align="left">Methanolic extract of leaf and stem</td><td align="left"><italic>E. coli</italic>, <italic>Shigella dysenteriae</italic>, <italic>S. typhi</italic>, <italic>C. albicans</italic>, <italic>P. aeruginosa</italic></td><td align="left">Tekwu et al. (<xref ref-type="bibr" rid="CR82">2012</xref>)</td></tr><tr><td align="left">
<italic>Rhus coriaria</italic>
</td><td align="left">Ethanolic extract</td><td align="left">MDR <italic>P. aeruginosa</italic></td><td align="left">Adwan et al. (<xref ref-type="bibr" rid="CR1">2010</xref>)</td></tr></tbody></table><table-wrap-foot><p>MDRsM&#x000a0;=&#x000a0;<italic>Staphylococcus aureus</italic>&#x000a0;+&#x000a0;<italic>Acinetobacter</italic> sp.&#x000a0;+&#x000a0;<italic>Citrobacter freundii</italic>&#x000a0;+&#x000a0;<italic>Chromobacterium violaceum</italic>&#x000a0;+&#x000a0;<italic>Escherichia coli</italic>&#x000a0;+&#x000a0;<italic>Klebsiella</italic> sp.&#x000a0;+&#x000a0;<italic>Proteus</italic> sp.&#x000a0;+&#x000a0;<italic>Pseudomonas aeruginosa</italic>&#x000a0;+&#x000a0;<italic>Salmonella typhi</italic>&#x000a0;+&#x000a0;<italic>Vibrio cholera</italic>; MDRsG&#x000a0;+&#x000a0;ve&#x000a0;=&#x000a0;<italic>S. aureus</italic> (MRSA)&#x000a0;+&#x000a0;<italic>Streptococcus pyogenes</italic>&#x000a0;+&#x000a0;<italic>Enterococcus faecalis</italic> (VRE); MDRsG&#x02212;ve&#x000a0;=&#x000a0;<italic>Acinetobacter baumannii</italic>&#x000a0;+&#x000a0;<italic>Citrobacter freundii</italic>&#x000a0;+&#x000a0;<italic>Proteus mirabilis</italic>&#x000a0;+&#x000a0;<italic>Proteus vulgaris</italic>&#x000a0;+&#x000a0;<italic>Pseudomonas aeruginosa</italic></p></table-wrap-foot></table-wrap><table-wrap id="Tab3"><label>Table&#x000a0;3</label><caption><p>Examples of plant derivatives and their antimicrobial activities</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Plant-derived antimicrobial groups</th><th align="left">Structure</th><th align="left">Chemical properties</th><th align="left">Effective on microbes</th><th align="left">References</th></tr></thead><tbody><tr><td align="left" rowspan="2">Quinones</td><td align="left" rowspan="2">
<inline-graphic xlink:href="13205_2013_180_Figa_HTML.gif" id="d29e1716"/>
</td><td align="left">Conjugated cyclic-dione structure with molecular formula C<sub>6</sub>H<sub>4</sub>O<sub>2</sub> e.g. Anthraquinone from <italic>Cassia italica</italic></td><td align="left"><italic>Pseudomonas pseudomallei</italic>, <italic>Bacillus anthracis</italic>, <italic>Corynebacterium pseudodiphthericum</italic>, <italic>Pseudomonas aeruginosa</italic></td><td align="left">Kazmi et al. (<xref ref-type="bibr" rid="CR48">1994</xref>)</td></tr><tr><td align="left">6-(4,7 Dihydroxy-heptyl)quinone</td><td align="left"><italic>Staphylococcus aureus</italic>, <italic>Bacillus subtilis</italic>, <italic>Proteus vulgaris</italic></td><td align="left">Ignacimuthu et al. (<xref ref-type="bibr" rid="CR43">2009</xref>)</td></tr><tr><td align="left" rowspan="2">Alkaloids</td><td align="left" rowspan="2">
<inline-graphic xlink:href="13205_2013_180_Figb_HTML.gif" id="d29e1779"/>
</td><td align="left">Naturally occurring amines having nitrogen in heterocyclic ring of compounds and are the derivative amino acids e.g. glabradine from tubers of <italic>Stephania glabra</italic></td><td align="left"><italic>S. aureus</italic>, <italic>S. mutans</italic>, <italic>Microsporum gypseum</italic>, <italic>M. canis</italic>, <italic>Trichophyton rubrum</italic></td><td align="left">Semwal and Rawat (<xref ref-type="bibr" rid="CR76">2009</xref>)</td></tr><tr><td align="left"><sc>l</sc>-Proline derived Monophyllidin from <italic>Zanthoxylum monophyllum</italic></td><td align="left">
<italic>Enterococcus faecalis</italic>
</td><td align="left">Patino and Cuca (<xref ref-type="bibr" rid="CR66">2011</xref>)</td></tr><tr><td align="left">Lectins and polypeptides</td><td align="left">&#x02013;</td><td align="left">Lectins are carbohydrate binding proteins (phytoaglutinin) with MW around 17,000&#x02013;400,000</td><td align="left"><italic>E. coli</italic>, <italic>P. aeruginosa</italic>, <italic>Enterococcus hirae</italic>, <italic>Candida albicans</italic> (fungi)</td><td align="left">(Zhang and Lewis (<xref ref-type="bibr" rid="CR94">1997</xref>)</td></tr><tr><td align="left">Flavones/flavonoids/flavonols</td><td align="left">
<inline-graphic xlink:href="13205_2013_180_Figc_HTML.gif" id="d29e1866"/>
</td><td align="left">Are ubiquitous in plant&#x02019;s parts, fruits, seeds, flowers and even honey. Flavones are hydroxylated phenolics containing one carbonyl group</td><td align="left">MDR <italic>Klebsiella pneumoniae</italic>, <italic>P. aeruginosa</italic>, <italic>E. coli</italic></td><td align="left">&#x000d6;z&#x000e7;elik et al. (<xref ref-type="bibr" rid="CR64">2008</xref>); Edziri et al. (<xref ref-type="bibr" rid="CR27">2012</xref>)</td></tr><tr><td align="left">Coumarins</td><td align="left">
<inline-graphic xlink:href="13205_2013_180_Figd_HTML.gif" id="d29e1899"/>
</td><td align="left">Coumarins are phenolic substances made of fused benzene and alpha pyrone ring forming toxic compounds found in plants such as <italic>Dipteryx odorata</italic>, <italic>Anthoxanthum odoratum</italic> etc</td><td align="left"><italic>S. mutans</italic>, <italic>S. viridans</italic>, <italic>S. aureus</italic></td><td align="left">Widelski et al. (<xref ref-type="bibr" rid="CR92">2009</xref>); Lewis and Ausubel (<xref ref-type="bibr" rid="CR53">2006</xref>)</td></tr><tr><td align="left">Terpenoids and essential oils</td><td align="left">
<inline-graphic xlink:href="13205_2013_180_Fige_HTML.gif" id="d29e1937"/>
</td><td align="left">Isoprene derivatives having a general formula C<sub>10</sub>H<sub>16</sub> therefore also called as Isoprenoids. Well-known examples include menthol</td><td align="left"><italic>S. viridans</italic>, <italic>S. aureus</italic>, <italic>E. coli</italic>, <italic>B. subtilis</italic>, <italic>Shigella sonnei</italic> (highly active) <italic>P. aeruginosa</italic>, <italic>E. coli</italic>, <italic>S. aureus</italic>, <italic>T. mentagrophytes</italic> (low activity)</td><td align="left">Banso (<xref ref-type="bibr" rid="CR8">2009</xref>); Ragasa et al. (<xref ref-type="bibr" rid="CR67">2008</xref>)</td></tr><tr><td align="left">Tannins</td><td align="left">
<inline-graphic xlink:href="13205_2013_180_Figf_HTML.gif" id="d29e1995"/>
</td><td align="left">Large polyphenolic compound containing sufficient hydroxyls and other suitable groups</td><td align="left"><italic>S. aureus</italic>, <italic>S. typhimurium</italic>,</td><td align="left">Moneim et al. (<xref ref-type="bibr" rid="CR59">2007</xref>)</td></tr></tbody></table><table-wrap-foot><p>Chemical structure given in front of corresponding group of antimicrobials is not to be considered as generalized one, the references are in correspondence with bacteria</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec6"><title>Synergistic actions of PDA<sub>m</sub>s</title><p>The AMR is conferred by several factors which have already been reviewed in previous sections. Plasmid encoded resistance facilitate bacterial cells to develop resistance of various degrees. For instance, unlike Gram-positive, MDR Gram-negative bacterial species have developed a sophisticated permeability barrier as outer membrane comprised of hydrophilic lipopolysaccharide restricting the entry of hydrophobic (quinones and alkaloids) and amphipathic antibiotic compounds (Lewis and Ausubel <xref ref-type="bibr" rid="CR53">2006</xref>). The biased effect of PDA<sub>m</sub>s on Gram-positive and -negative species has been a key to the discovery of the synergistic compounds of plant origin (Lewis <xref ref-type="bibr" rid="CR52">2001</xref>). Plant antimicrobials act well in combinations with other amphipathic compounds. In addition to this, resistance in MDRs conferred by efflux pumping can be treated with the synergistic combinations of antimicrobial with an efflux pump inhibitor (EPI) and altering outer membrane permeability of MDR bacteria providing an effective drug (Savage <xref ref-type="bibr" rid="CR74">2001</xref>; Gibbons <xref ref-type="bibr" rid="CR33">2004</xref>; Baskaran et al. <xref ref-type="bibr" rid="CR10">2009</xref>). Studies of Chusri et al. (<xref ref-type="bibr" rid="CR19">2009</xref>) reported another example of synergistic effect of plant-derived phenolics such as Ellagic acid (a derivative of Gallic acid) a non-antimicrobial, administered as EPI in combination with classical antibiotic to control <italic>Acinetobacter baumannii.</italic> Another example belongs to the well-studied plant <italic>Berberis fremontii</italic> and its amphipathic cation berberine inhibits the NorA MDR pump of <italic>Staphylococcus</italic><italic>aureus</italic> when applied in combination with 5&#x02032;-MHC (5&#x02032;-methoxyhydnocarpin, an amphipathic weak acid) a real inhibitor of the pump enhancing the activity of berberine (Stermitz et al. <xref ref-type="bibr" rid="CR79">2000</xref>). Similar non-antimicrobial compounds known to enhance effectivity of antimicrobials have been discussed by Lewis (<xref ref-type="bibr" rid="CR52">2001</xref>). Detailed mechanism of PDA<sub>m</sub>s on MDR <italic>S. aureus</italic> has been discussed in the review by Gibbons (<xref ref-type="bibr" rid="CR33">2004</xref>). Wang et al. (<xref ref-type="bibr" rid="CR89">2009</xref>) defined that the role of AMP plant defensin IbAMP1 isolated from plant <italic>Impatiens balsamina</italic> have a prime target, intercellular components, forming small channels that permit the transit of ions or protons across the bacterial membrane, the same activity was also observed in the linear analogs of this peptide.</p></sec><sec id="Sec7"><title>Future studies</title><p>Researches on the AMR and alternating drug system are endless and a lot of scope is there in the field of ethno-pharmacology. Scientists are working on the development of safe and effective antimicrobials all over the world. Future studies may involve the development of new plant-derived synergistic compounds capable of enhancing the activity of PDA<sub>m</sub>s. A lot of research potential is also there to answer the questions for e.g. mechanism of resistance in different bacterial species, development of XDRs and their control.</p></sec><sec id="Sec8"><title>Conclusion</title><p>AMR is a worldwide problem. Research literatures suggest that the substandard living in major parts of developing world is one of the major causes of the development of resistance among bacteria. The developed world is also vulnerable of getting widespread infections for e.g. USA is surrounded by the developing countries having high rates of resistance development. Nosocomial, water borne, health care systems and food products especially meats are some of the most common means of widespread of resistant gene globally. Thanks to the modern molecular approaches for making better understanding of the pathways of resistance development and its remedy. Pharmacologists are developing new antibiotic drugs to treat and control various infections, however; the chances of the development of resistance are equal to the emergence of new drugs. In addition, research suggest that the combinations of PDA<sub>m</sub>s and the synergistic compounds work efficiently on resistant strains ensuring no further resistance development. Moreover; concerted efforts have been solicited by the world community because poor countries are worst affected by the antimicrobial resistance and the developed countries are no longer safe (Di&#x000e1;z-Granados et al. <xref ref-type="bibr" rid="CR23">2008</xref>). In this regard, PDA<sub>m</sub>s in combination with plant-derived synergistic compounds may be the cost-effective approach to deal with global antimicrobial resistance.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>MDR</term><def><p>Multidrug-resistant</p></def></def-item><def-item><term>XDR</term><def><p>Extensively drug-resistant</p></def></def-item><def-item><term>AMR</term><def><p>Antimicrobial resistance</p></def></def-item><def-item><term>PDA<sub>m</sub></term><def><p>Plant-derived antimicrobials</p></def></def-item><def-item><term>ARM</term><def><p>Antimicrobial-resistant microbes</p></def></def-item><def-item><term>EPI</term><def><p>Efflux pump inhibitor</p></def></def-item><def-item><term>AMP</term><def><p>Antimicrobial peptides</p></def></def-item></def-list></glossary><ack><p>The Corresponding and the one of the main contributors of this review article Dr. Jatin K Srivastava is acknowledged to the chairman of Global Group of Institutions Lucknow for providing the necessary facilities during the compilation of this review paper.</p><sec id="d29e2110"><title>Conflict of interest</title><p>Authors have no conflict of interest with any of the organization, funding agencies or any person.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adwan</surname><given-names>G</given-names></name><name><surname>Abu-Shanab</surname><given-names>B</given-names></name><name><surname>Adwan</surname><given-names>K</given-names></name></person-group><article-title>Antibacterial activities of some plant extracts alone and in combination with different antimicrobials against multidrug resistant <italic>Pseudomonas aeruginosa</italic> strains</article-title><source>Asian Pac J Trop Med</source><year>2010</year><volume>3</volume><issue>4</issue><fpage>266</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1016/S1995-7645(10)60064-8</pub-id></element-citation></ref><ref id="CR2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aerts</surname><given-names>AM</given-names></name><name><surname>Carmona-Gutierrez</surname><given-names>D</given-names></name><name><surname>Lefevre</surname><given-names>S</given-names></name><name><surname>Govaert</surname><given-names>G</given-names></name><name><surname>Fran&#x000e7;ois</surname><given-names>IE</given-names></name><name><surname>Madeo</surname><given-names>F</given-names></name><name><surname>Santos</surname><given-names>R</given-names></name><name><surname>Cammue</surname><given-names>BP</given-names></name><name><surname>Thevissen</surname><given-names>K</given-names></name></person-group><article-title>The antifungal plant defensin RsAFP2 from radish induces apoptosis in a metacaspase independent way in <italic>Candida albicans</italic></article-title><source>FEBS Lett</source><year>2009</year><volume>583</volume><issue>15</issue><fpage>2513</fpage><lpage>2516</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2009.07.004</pub-id><pub-id pub-id-type="pmid">19596007</pub-id></element-citation></ref><ref id="CR3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>AS</given-names></name><name><surname>Elgorashi</surname><given-names>EE</given-names></name><name><surname>Moodley</surname><given-names>N</given-names></name><name><surname>McGaw</surname><given-names>LJ</given-names></name><name><surname>Naidoo</surname><given-names>V</given-names></name><name><surname>Eloff</surname><given-names>JN</given-names></name></person-group><article-title>The antimicrobial, antioxidative, anti-inflammatory activity and cytotoxicity of different fractions of four South African <italic>Bauhinia</italic> species used traditionally to treat diarrhea</article-title><source>J Ethnopharmacol</source><year>2012</year><volume>143</volume><issue>3</issue><fpage>826</fpage><lpage>839</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2012.08.004</pub-id><pub-id pub-id-type="pmid">22917809</pub-id></element-citation></ref><ref id="CR4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aliahmadi</surname><given-names>A</given-names></name><name><surname>Roghanian</surname><given-names>R</given-names></name><name><surname>Emtiazi</surname><given-names>G</given-names></name><name><surname>Mirzajani</surname><given-names>F</given-names></name><name><surname>Ghassempour</surname><given-names>A</given-names></name></person-group><article-title>Identification and primary characterization of a plant antimicrobial peptide with remarkable inhibitory effects against antibiotic resistant bacteria</article-title><source>Afr J Biotechnol</source><year>2012</year><volume>11</volume><issue>40</issue><fpage>9672</fpage><lpage>9676</lpage></element-citation></ref><ref id="CR5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali-Shtayeh</surname><given-names>MS</given-names></name><name><surname>Al-Nuri</surname><given-names>MA</given-names></name><name><surname>Yaghmour</surname><given-names>RMR</given-names></name><name><surname>Faidi</surname><given-names>YR</given-names></name></person-group><article-title>Antimicrobial activity of <italic>Micromeria</italic><italic>nervosa</italic> from the Palestinian area</article-title><source>J Ethnopharmacol</source><year>1997</year><volume>58</volume><fpage>143</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(97)00088-3</pub-id><pub-id pub-id-type="pmid">9421249</pub-id></element-citation></ref><ref id="CR6"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Am&#x000e1;bile-Cuevas</surname><given-names>CF</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Am&#x000e1;bile-Cuevas</surname><given-names>CF</given-names></name></person-group><article-title>Gathering of resistance genes in Gram-negative bacteria: an overview</article-title><source>Multidrug resistant bacteria</source><year>2003</year><publisher-loc>Wymondham</publisher-loc><publisher-name>Horizon Scientific Press</publisher-name><fpage>9</fpage><lpage>31</lpage></element-citation></ref><ref id="CR7"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Am&#x000e1;bile-Cuevas</surname><given-names>CF</given-names></name><etal/></person-group><person-group person-group-type="editor"><name><surname>de-J-Soso</surname><given-names>A</given-names></name><etal/></person-group><article-title>Global perspective of antibiotic resistance</article-title><source>Antimicrobial resistance in developing countries</source><year>2010</year><publisher-loc>New York</publisher-loc><publisher-name>Springer</publisher-name><fpage>3</fpage><lpage>14</lpage></element-citation></ref><ref id="CR8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banso</surname><given-names>A</given-names></name></person-group><article-title>Phytochemical and antibacterial investigation of bark extracts of <italic>Acacia</italic><italic>nilotica</italic></article-title><source>J Med Plants Res</source><year>2009</year><volume>3</volume><issue>2</issue><fpage>82</fpage><lpage>85</lpage></element-citation></ref><ref id="CR9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baris</surname><given-names>O</given-names></name><name><surname>Gulluce</surname><given-names>M</given-names></name><name><surname>Sahin</surname><given-names>F</given-names></name><name><surname>Ozer</surname><given-names>H</given-names></name><name><surname>Kilic</surname><given-names>HH</given-names></name><name><surname>Ozkan</surname><given-names>H</given-names></name><name><surname>Sokmen</surname><given-names>M</given-names></name><name><surname>Ozbek</surname><given-names>T</given-names></name></person-group><article-title>Biological activities of the essential oil and methanolic extract of <italic>Achillea biebersteinii</italic> Afan. (Asteraceae)</article-title><source>Turk J Biol</source><year>2006</year><volume>30</volume><fpage>65</fpage><lpage>73</lpage></element-citation></ref><ref id="CR10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baskaran</surname><given-names>SA</given-names></name><name><surname>Kazmer</surname><given-names>GW</given-names></name><name><surname>Hinckley</surname><given-names>L</given-names></name><name><surname>Andrew</surname><given-names>JM</given-names></name><name><surname>Venkitanarayanan</surname><given-names>K</given-names></name></person-group><article-title>Antimicrobial effect of plant derived antimicrobials on major bacterial mastitis pathogens in vitro</article-title><source>J Dairy Sci</source><year>2009</year><volume>92</volume><issue>4</issue><fpage>1423</fpage><lpage>1429</lpage><pub-id pub-id-type="doi">10.3168/jds.2008-1384</pub-id><pub-id pub-id-type="pmid">19307623</pub-id></element-citation></ref><ref id="CR11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brouwer</surname><given-names>CPJM</given-names></name><name><surname>Rahman</surname><given-names>M</given-names></name><name><surname>Welling</surname><given-names>MM</given-names></name></person-group><article-title>Discovery and development of a synthetic peptide derived from lactoferrin for clinical use</article-title><source>Peptide</source><year>2011</year><volume>32</volume><issue>9</issue><fpage>1953</fpage><lpage>1963</lpage><pub-id pub-id-type="doi">10.1016/j.peptides.2011.07.017</pub-id></element-citation></ref><ref id="CR12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bush</surname><given-names>K</given-names></name></person-group><article-title>Antibacterial drug discovery in the 21st century</article-title><source>Clin Microbiol Infect</source><year>2004</year><volume>10</volume><issue>S4</issue><fpage>10</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1111/j.1465-0691.2004.1005.x</pub-id><pub-id pub-id-type="pmid">15522035</pub-id></element-citation></ref><ref id="CR13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bush</surname><given-names>K</given-names></name><name><surname>Fisher</surname><given-names>JF</given-names></name></person-group><article-title>Epidemiological expansion, structural studies, and clinical challenges of new &#x003b2;-lactamases from Gram-negative bacteria</article-title><source>Annu Rev Microbiol</source><year>2011</year><volume>65</volume><fpage>455</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1146/annurev-micro-090110-102911</pub-id><pub-id pub-id-type="pmid">21740228</pub-id></element-citation></ref><ref id="CR14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byarugaba</surname><given-names>DK</given-names></name></person-group><article-title>Antimicrobial resistance in developing countries and responsible risk factors</article-title><source>Int J Antimicrob Agents</source><year>2004</year><volume>24</volume><issue>2</issue><fpage>105</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2004.02.015</pub-id><pub-id pub-id-type="pmid">15288307</pub-id></element-citation></ref><ref id="CR15"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Byarugaba</surname><given-names>DK</given-names></name><etal/></person-group><person-group person-group-type="editor"><name><surname>de-J-Soso</surname><given-names>A</given-names></name><etal/></person-group><article-title>Mechanism of antimicrobial resistance</article-title><source>Antimicrobial resistance in developing countries</source><year>2010</year><publisher-loc>New York</publisher-loc><publisher-name>Springer</publisher-name><fpage>15</fpage><lpage>26</lpage></element-citation></ref><ref id="CR16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campion</surname><given-names>JJ</given-names></name><name><surname>McNamara</surname><given-names>PJ</given-names></name><name><surname>Evans</surname><given-names>ME</given-names></name></person-group><article-title>Evolution of ciprofloxacin-resistant <italic>Staphylococcus aureus</italic> in in vitro pharmacokinetic environments</article-title><source>Antimicrob Agents Chemother</source><year>2004</year><volume>48</volume><issue>12</issue><fpage>4733</fpage><lpage>4744</lpage><pub-id pub-id-type="doi">10.1128/AAC.48.12.4733-4744.2004</pub-id><pub-id pub-id-type="pmid">15561851</pub-id></element-citation></ref><ref id="CR17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceccarelli</surname><given-names>D</given-names></name><name><surname>Salvia</surname><given-names>AM</given-names></name><name><surname>Sami</surname><given-names>J</given-names></name><name><surname>Cappuccinelli</surname><given-names>P</given-names></name><name><surname>Colombo</surname><given-names>MM</given-names></name></person-group><article-title>New cluster of plasmid-located class 1 integrons in <italic>Vibrio</italic><italic>cholerae</italic> O1 and a <italic>dfrA15</italic> cassette containing integron in <italic>Vibrio</italic><italic>parahaemolyticus</italic> isolated in Angola</article-title><source>Antimicrob Agents Chemother</source><year>2006</year><volume>50</volume><fpage>2493</fpage><lpage>2499</lpage><pub-id pub-id-type="doi">10.1128/AAC.01310-05</pub-id><pub-id pub-id-type="pmid">16801431</pub-id></element-citation></ref><ref id="CR18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>C</given-names></name><name><surname>Chang</surname><given-names>W</given-names></name><name><surname>Chang</surname><given-names>S</given-names></name><name><surname>Cheng</surname><given-names>S</given-names></name></person-group><article-title>Antibacterial activities of plant essential oils against <italic>Legionella pneumophila</italic></article-title><source>Water Res</source><year>2008</year><volume>42</volume><fpage>278</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1016/j.watres.2007.07.008</pub-id><pub-id pub-id-type="pmid">17659763</pub-id></element-citation></ref><ref id="CR19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chusri</surname><given-names>S</given-names></name><name><surname>Villanueva</surname><given-names>I</given-names></name><name><surname>Voravuthikunchai</surname><given-names>SP</given-names></name><name><surname>Davies</surname><given-names>J</given-names></name></person-group><article-title>Enhancing antibiotic activity: a strategy to control <italic>Acinetobacter</italic> infections</article-title><source>J Antimicrob Chemother</source><year>2009</year><volume>16</volume><fpage>1203</fpage><lpage>1211</lpage><pub-id pub-id-type="doi">10.1093/jac/dkp381</pub-id><pub-id pub-id-type="pmid">19861335</pub-id></element-citation></ref><ref id="CR20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coffey</surname><given-names>TJ</given-names></name><name><surname>Dowson</surname><given-names>CG</given-names></name><name><surname>Daniels</surname><given-names>M</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Martin</surname><given-names>C</given-names></name><name><surname>Spratt</surname><given-names>BG</given-names></name><name><surname>Musser</surname><given-names>JM</given-names></name></person-group><article-title>Horizontal transfer of multiple penicillin-binding protein genes and capsular biosynthetic genes in natural populations of <italic>Streptococcus pneumoniae</italic></article-title><source>Mol Microbiol</source><year>1991</year><volume>5</volume><issue>9</issue><fpage>2255</fpage><lpage>2260</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.1991.tb02155.x</pub-id><pub-id pub-id-type="pmid">1766389</pub-id></element-citation></ref><ref id="CR21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cowan</surname><given-names>MM</given-names></name></person-group><article-title>Plant products as antimicrobial agents</article-title><source>Clin Microbiol Rev</source><year>1999</year><volume>12</volume><issue>4</issue><fpage>564</fpage><lpage>582</lpage><pub-id pub-id-type="pmid">10515903</pub-id></element-citation></ref><ref id="CR22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>K</given-names></name><name><surname>Tiwari</surname><given-names>RKS</given-names></name><name><surname>Shrivastava</surname><given-names>DK</given-names></name></person-group><article-title>Techniques for evaluation of medicinal plant products as antimicrobial agent: current methods and future trends</article-title><source>J Med Plant Res</source><year>2010</year><volume>4</volume><issue>2</issue><fpage>104</fpage><lpage>111</lpage></element-citation></ref><ref id="CR23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di&#x000e1;z-Granados</surname><given-names>CA</given-names></name><name><surname>Cardo</surname><given-names>DM</given-names></name><name><surname>McGowan-Jr</surname><given-names>JE</given-names></name></person-group><article-title>Antimicrobial resistance: international control strategies with a focus on limited resource settings</article-title><source>Int J Antimicrob Agents</source><year>2008</year><volume>32</volume><issue>1</issue><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2008.03.002</pub-id><pub-id pub-id-type="pmid">18550343</pub-id></element-citation></ref><ref id="CR24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x000ed;az-Mej&#x000ed;a</surname><given-names>JJ</given-names></name><name><surname>Am&#x000e1;bile-Cuevas</surname><given-names>CF</given-names></name><name><surname>Rosas</surname><given-names>I</given-names></name><name><surname>Souza</surname><given-names>V</given-names></name></person-group><article-title>An analysis of the evolutionary relationships of integron integrases with emphasis on the prevalence of class1 integron in <italic>Escherichia coli</italic> isolates from clinical and environmental origins</article-title><source>Microbiol</source><year>2008</year><volume>154</volume><fpage>94</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1099/mic.0.2007/008649-0</pub-id></element-citation></ref><ref id="CR25"><mixed-citation publication-type="other">Dubey D, Padhy RN (2013) Antibacterial activity of <italic>Lantana camara</italic> L. against multidrug resistant pathogens from ICU patients of a teaching hospital. JHerb Med (In press). doi:10.1016/j.hermed.2012.12.002</mixed-citation></ref><ref id="CR26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubey</surname><given-names>D</given-names></name><name><surname>Sahu</surname><given-names>MC</given-names></name><name><surname>Rath</surname><given-names>S</given-names></name><name><surname>Paty</surname><given-names>BP</given-names></name><name><surname>Debata</surname><given-names>NK</given-names></name><name><surname>Padhy</surname><given-names>RN</given-names></name></person-group><article-title>Antimicrobial activity of medicinal plants used by aborigines of Kalahandi, Orissa, India against multidrug resistant bacteria</article-title><source>Asian Pac J Trop Biomed</source><year>2012</year><volume>2</volume><issue>2</issue><fpage>S846</fpage><lpage>S854</lpage><pub-id pub-id-type="doi">10.1016/S2221-1691(12)60322-0</pub-id></element-citation></ref><ref id="CR27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edziri</surname><given-names>H</given-names></name><name><surname>Mastouri</surname><given-names>M</given-names></name><name><surname>Mahjoub</surname><given-names>MA</given-names></name><name><surname>Mighri</surname><given-names>Z</given-names></name><name><surname>Mahjoub</surname><given-names>A</given-names></name><name><surname>Verschaeve</surname><given-names>L</given-names></name></person-group><article-title>Antibacterial, antifungal and cytotoxic activities of two flavonoids from <italic>Retama</italic><italic>raetam</italic> flowers</article-title><source>Molecules</source><year>2012</year><volume>17</volume><fpage>7284</fpage><lpage>7293</lpage><pub-id pub-id-type="doi">10.3390/molecules17067284</pub-id><pub-id pub-id-type="pmid">22695233</pub-id></element-citation></ref><ref id="CR28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emeka</surname><given-names>PM</given-names></name><name><surname>Badger-Emeka</surname><given-names>LI</given-names></name><name><surname>Fateru</surname><given-names>F</given-names></name></person-group><article-title>In-vitro antimicrobial activities of <italic>Acalypha ornata</italic> leaf extracts on bacterial and fungal clinical isolates</article-title><source>J Herb Med</source><year>2012</year><volume>2</volume><issue>4</issue><fpage>136</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1016/j.hermed.2012.09.001</pub-id></element-citation></ref><ref id="CR29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fonseca</surname><given-names>EL</given-names></name><name><surname>dos Santos Freitas</surname><given-names>FF</given-names></name><name><surname>Vieira</surname><given-names>VV</given-names></name><name><surname>Vicente</surname><given-names>ACP</given-names></name></person-group><article-title>New <italic>qnr</italic> gene cassettes associated with superintegron repeats in <italic>Vibrio</italic><italic>cholerae</italic> O1</article-title><source>Emerg Infect Dis</source><year>2008</year><volume>14</volume><fpage>1129</fpage><lpage>1131</lpage><pub-id pub-id-type="doi">10.3201/eid1407.080132</pub-id><pub-id pub-id-type="pmid">18598639</pub-id></element-citation></ref><ref id="CR30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gandhi</surname><given-names>NR</given-names></name><name><surname>Moll</surname><given-names>A</given-names></name><name><surname>Sturm</surname><given-names>AW</given-names></name><name><surname>Pawinski</surname><given-names>R</given-names></name><name><surname>Govender</surname><given-names>T</given-names></name><name><surname>Lalloo</surname><given-names>U</given-names></name><name><surname>Zeller</surname><given-names>K</given-names></name><name><surname>Andrews</surname><given-names>J</given-names></name><name><surname>Friedland</surname><given-names>G</given-names></name></person-group><article-title>Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa</article-title><source>Lancet Infect Dis</source><year>2006</year><volume>368</volume><fpage>1575</fpage><lpage>1580</lpage></element-citation></ref><ref id="CR31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghafur</surname><given-names>A</given-names></name></person-group><article-title>The Chennai declaration: an Indian perspective on the antimicrobial resistance challenge</article-title><source>J Global Antimicrob Resist</source><year>2013</year><volume>1</volume><issue>1</issue><fpage>5</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.jgar.2013.01.003</pub-id></element-citation></ref><ref id="CR32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghafur</surname><given-names>A</given-names></name><name><surname>Mathai</surname><given-names>D</given-names></name><name><surname>Muruganathan</surname><given-names>A</given-names></name><name><surname>Jayalal</surname><given-names>JA</given-names></name><name><surname>Kant</surname><given-names>R</given-names></name><name><surname>Chaudhary</surname><given-names>D</given-names></name><name><surname>Prabhash</surname><given-names>K</given-names></name><name><surname>Abraham</surname><given-names>OC</given-names></name><name><surname>Gopalakrishnan</surname><given-names>R</given-names></name><name><surname>Ramasubramanian</surname><given-names>V</given-names></name><name><surname>Shah</surname><given-names>SN</given-names></name><name><surname>Pardeshi</surname><given-names>R</given-names></name><name><surname>Huilgol</surname><given-names>A</given-names></name><name><surname>Kapil</surname><given-names>A</given-names></name><name><surname>Gill</surname><given-names>JPS</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>RIssam</surname><given-names>HS</given-names></name><name><surname>Todi</surname><given-names>S</given-names></name><name><surname>Hegde</surname><given-names>BM</given-names></name><name><surname>Parikh</surname><given-names>P</given-names></name></person-group><article-title>The Chennai declaration: recommendations of &#x0201c;A roadmap to tackle the challenge of antimicrobial resistance&#x0201d;&#x02014;a joint meeting of medical societies of India</article-title><source>Indian J Cancer</source><year>2012</year><volume>49</volume><issue>4</issue><fpage>84</fpage><lpage>94</lpage></element-citation></ref><ref id="CR33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibbons</surname><given-names>S</given-names></name></person-group><article-title>Anti-staphylococcal plant natural products</article-title><source>Nat Prod Rep</source><year>2004</year><volume>21</volume><fpage>263</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1039/b212695h</pub-id><pub-id pub-id-type="pmid">15042149</pub-id></element-citation></ref><ref id="CR34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giske</surname><given-names>CG</given-names></name><name><surname>Cornaglia</surname><given-names>G</given-names></name></person-group><article-title>Supranational surveillance of antimicrobial resistance: the legacy of the last decade and proposals for the future</article-title><source>Drug Resist Updat</source><year>2010</year><volume>13</volume><issue>4&#x02013;5</issue><fpage>93</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.drup.2010.08.002</pub-id><pub-id pub-id-type="pmid">20864384</pub-id></element-citation></ref><ref id="CR35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x000e1;lez-Lomothe</surname><given-names>R</given-names></name><name><surname>Mitchell</surname><given-names>G</given-names></name><name><surname>Gattuso</surname><given-names>M</given-names></name><name><surname>Diarra</surname><given-names>MS</given-names></name><name><surname>Malouim</surname><given-names>F</given-names></name><name><surname>Bouarab</surname><given-names>K</given-names></name></person-group><article-title>Plant antimicrobial agents and their effects on plant and human pathogens</article-title><source>Int J Mol Sci</source><year>2009</year><volume>10</volume><fpage>3400</fpage><lpage>3419</lpage><pub-id pub-id-type="doi">10.3390/ijms10083400</pub-id><pub-id pub-id-type="pmid">20111686</pub-id></element-citation></ref><ref id="CR36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goossens</surname><given-names>H</given-names></name></person-group><article-title>The Chennai declaration on antimicrobial resistance in India</article-title><source>Lancet Infect Dis</source><year>2013</year><volume>13</volume><issue>2</issue><fpage>105</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(12)70346-8</pub-id><pub-id pub-id-type="pmid">23347623</pub-id></element-citation></ref><ref id="CR37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grohman</surname><given-names>E</given-names></name><name><surname>Muth</surname><given-names>G</given-names></name><name><surname>Espinosa</surname><given-names>M</given-names></name></person-group><article-title>Conjugative plasmid transfer in Gram-positive bacteria</article-title><source>Microbial Mol Biol Rev</source><year>2003</year><volume>67</volume><issue>2</issue><fpage>277</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1128/MMBR.67.2.277-301.2003</pub-id></element-citation></ref><ref id="CR38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hancock</surname><given-names>EW</given-names></name></person-group><article-title>Mechanisms of action of newer antibiotics for Gram-positive pathogens</article-title><source>Lancet Infect Dis</source><year>2005</year><volume>5</volume><issue>4</issue><fpage>209</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(05)70051-7</pub-id><pub-id pub-id-type="pmid">15792738</pub-id></element-citation></ref><ref id="CR39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiramatsu</surname><given-names>K</given-names></name><name><surname>Katayama</surname><given-names>Y</given-names></name><name><surname>Yuzawa</surname><given-names>H</given-names></name><name><surname>Ito</surname><given-names>T</given-names></name></person-group><article-title>Molecular genetics of methicillin-resistant <italic>Staphylococcus</italic><italic>aureus</italic></article-title><source>Int J Med Microbiol</source><year>2002</year><volume>292</volume><fpage>67</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1078/1438-4221-00192</pub-id><pub-id pub-id-type="pmid">12195737</pub-id></element-citation></ref><ref id="CR40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>S</given-names></name><name><surname>Chiu</surname><given-names>T</given-names></name><name><surname>Pang</surname><given-names>J</given-names></name><name><surname>Hsuan-Yuan</surname><given-names>C</given-names></name><name><surname>Chang</surname><given-names>G</given-names></name><name><surname>Tsen</surname><given-names>H</given-names></name></person-group><article-title>Characterization of antimicrobial resistance patterns and class 1 integrons among <italic>Escherichia coli</italic> and <italic>Salmonella enterica</italic> serovar Choleraesuis strains isolated from humans and swine in Taiwan</article-title><source>Int J Antimicrob Agents</source><year>2006</year><volume>27</volume><issue>5</issue><fpage>383</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2005.11.020</pub-id><pub-id pub-id-type="pmid">16621462</pub-id></element-citation></ref><ref id="CR41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Hsueh</surname><given-names>P</given-names></name></person-group><article-title>Antimicrobial drug resistance in Taiwan</article-title><source>Int J Antimicrob Agents</source><year>2008</year><volume>32</volume><issue>3</issue><fpage>S174</fpage><lpage>S178</lpage><pub-id pub-id-type="doi">10.1016/S0924-8579(08)70023-2</pub-id><pub-id pub-id-type="pmid">19013350</pub-id></element-citation></ref><ref id="CR42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Igbinosa</surname><given-names>OO</given-names></name><name><surname>Igbinosa</surname><given-names>EO</given-names></name><name><surname>Aiyegoro</surname><given-names>OA</given-names></name></person-group><article-title>Antimicrobial activity and phytochemical screening of stem bark extracts from <italic>Jatropha curcas</italic> Linn</article-title><source>Afr J Pharma Phramacol</source><year>2009</year><volume>3</volume><issue>2</issue><fpage>58</fpage><lpage>62</lpage></element-citation></ref><ref id="CR43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ignacimuthu</surname><given-names>S</given-names></name><name><surname>Pavunraj</surname><given-names>M</given-names></name><name><surname>Duraipandiyan</surname><given-names>V</given-names></name><name><surname>Raja</surname><given-names>N</given-names></name><name><surname>Muthu</surname><given-names>C</given-names></name></person-group><article-title>Antibacterial activity of a novel quinone from the leaves of <italic>Pergularia</italic><italic>daemia</italic> (Forsk.), a traditional medicinal plant</article-title><source>Asian J Trad Med</source><year>2009</year><volume>4</volume><issue>1</issue><fpage>36</fpage><lpage>40</lpage></element-citation></ref><ref id="CR44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacoby</surname><given-names>GA</given-names></name><name><surname>Munoz-Price</surname><given-names>LS</given-names></name></person-group><article-title>The new B-lactamases</article-title><source>N Engl J Med</source><year>2005</year><volume>352</volume><fpage>380</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1056/NEJMra041359</pub-id><pub-id pub-id-type="pmid">15673804</pub-id></element-citation></ref><ref id="CR45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janovska</surname><given-names>D</given-names></name><name><surname>Kubikova</surname><given-names>K</given-names></name><name><surname>Kokoska</surname><given-names>L</given-names></name></person-group><article-title>Screening for antimicrobial activity of some medicinal plants species of traditional Chinese medicine</article-title><source>Czech J Food Sci</source><year>2003</year><volume>21</volume><issue>2</issue><fpage>107</fpage><lpage>110</lpage></element-citation></ref><ref id="CR46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadota</surname><given-names>S</given-names></name><name><surname>Basnet</surname><given-names>P</given-names></name><name><surname>Ishii</surname><given-names>E</given-names></name><name><surname>Tamura</surname><given-names>T</given-names></name><name><surname>Namba</surname><given-names>T</given-names></name></person-group><article-title>Antibacterial activity of trichorabdal A from <italic>Rabdosia trichocarpa</italic> against <italic>Helicobacter pylori</italic></article-title><source>Zentralbl Bakteriol</source><year>1997</year><volume>286</volume><issue>1</issue><fpage>63</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/S0934-8840(97)80076-X</pub-id><pub-id pub-id-type="pmid">9241802</pub-id></element-citation></ref><ref id="CR47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kartikeyan</surname><given-names>K</given-names></name><name><surname>Thirunarayan</surname><given-names>MA</given-names></name><name><surname>Krishnan</surname><given-names>P</given-names></name></person-group><article-title>Coexistence of <italic>bla</italic><sub><italic>OXA</italic>-23</sub> with <italic>bla</italic><sub>NDM1</sub> and <italic>armA</italic> in clinical isolates of <italic>Acinetobacter baumannii</italic> from India</article-title><source>J Antimicrob Chemother</source><year>2010</year><volume>65</volume><fpage>2253</fpage><lpage>2254</lpage><pub-id pub-id-type="doi">10.1093/jac/dkq273</pub-id><pub-id pub-id-type="pmid">20650909</pub-id></element-citation></ref><ref id="CR48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kazmi</surname><given-names>MH</given-names></name><name><surname>Malik</surname><given-names>A</given-names></name><name><surname>Hameed</surname><given-names>S</given-names></name><name><surname>Akhtar</surname><given-names>N</given-names></name><name><surname>Noor</surname><given-names>AS</given-names></name></person-group><article-title>An anthraquinone derivative from <italic>Cassia</italic><italic>italica</italic></article-title><source>Photochemistry</source><year>1994</year><volume>36</volume><fpage>761</fpage><lpage>763</lpage><pub-id pub-id-type="doi">10.1016/S0031-9422(00)89812-X</pub-id></element-citation></ref><ref id="CR49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuete</surname><given-names>V</given-names></name><name><surname>Alibert-Franco</surname><given-names>S</given-names></name><name><surname>Eyong</surname><given-names>KO</given-names></name><name><surname>Ngameni</surname><given-names>B</given-names></name><name><surname>Folefoc</surname><given-names>GN</given-names></name><name><surname>Nguemeving</surname><given-names>JR</given-names></name><name><surname>Tangmovo</surname><given-names>JG</given-names></name><name><surname>Fatso</surname><given-names>GW</given-names></name><name><surname>Komguem</surname><given-names>J</given-names></name><name><surname>Ouahouo</surname><given-names>BMW</given-names></name><name><surname>Bolla</surname><given-names>JM</given-names></name><name><surname>Chevalier</surname><given-names>J</given-names></name><name><surname>Ngadjui</surname><given-names>BT</given-names></name><name><surname>Nkengfack</surname><given-names>AE</given-names></name><name><surname>Pages</surname><given-names>JM</given-names></name></person-group><article-title>Antibacterial activity of some natural products against bacteria expressing a multi-drug-resistant phenotype</article-title><source>Int J Antimicrob Agents</source><year>2011</year><volume>37</volume><issue>2</issue><fpage>156</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2010.10.020</pub-id><pub-id pub-id-type="pmid">21163632</pub-id></element-citation></ref><ref id="CR50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumarasamy</surname><given-names>KK</given-names></name><name><surname>Toleman</surname><given-names>MA</given-names></name><name><surname>Walsh</surname><given-names>TR</given-names></name><name><surname>Bagaria</surname><given-names>J</given-names></name><name><surname>Butt</surname><given-names>F</given-names></name><name><surname>Balakrishnan</surname><given-names>P</given-names></name><name><surname>Chaudhary</surname><given-names>U</given-names></name><name><surname>Doumith</surname><given-names>M</given-names></name><name><surname>Giske</surname><given-names>CG</given-names></name><name><surname>Irfan</surname><given-names>S</given-names></name><name><surname>Krishna</surname><given-names>P</given-names></name><name><surname>Kumar</surname><given-names>AV</given-names></name><name><surname>Maharajan</surname><given-names>S</given-names></name><name><surname>Mushtaq</surname><given-names>S</given-names></name><name><surname>Noorie</surname><given-names>T</given-names></name><name><surname>Paterson</surname><given-names>DL</given-names></name><name><surname>Pearson</surname><given-names>A</given-names></name><name><surname>Perry</surname><given-names>C</given-names></name><name><surname>Pike</surname><given-names>C</given-names></name><name><surname>Rao</surname><given-names>B</given-names></name><name><surname>Ray</surname><given-names>U</given-names></name><name><surname>Sarma</surname><given-names>JB</given-names></name><name><surname>Sharma</surname><given-names>M</given-names></name><name><surname>Sheridan</surname><given-names>E</given-names></name><name><surname>Thirunarayan</surname><given-names>MA</given-names></name><name><surname>Turton</surname><given-names>J</given-names></name><name><surname>Upadhyay</surname><given-names>S</given-names></name><name><surname>Warner</surname><given-names>M</given-names></name><name><surname>Welfare</surname><given-names>W</given-names></name><name><surname>Livemore</surname><given-names>DM</given-names></name><name><surname>Woodford</surname><given-names>N</given-names></name></person-group><article-title>Emergence of a new antibiotic resistance mechanism in India, Pakistan and UK: a molecular, biological and epidemiological study</article-title><source>Lancet Infect Dis</source><year>2010</year><volume>10</volume><issue>9</issue><fpage>597</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(10)70143-2</pub-id><pub-id pub-id-type="pmid">20705517</pub-id></element-citation></ref><ref id="CR51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lalitha</surname><given-names>MK</given-names></name><name><surname>David</surname><given-names>T</given-names></name><name><surname>Thomas</surname><given-names>K</given-names></name></person-group><article-title>Nasopharyngeal swabs of school children, useful in rapid assessment of community antimicrobial resistance patterns in <italic>Streptococcus pneumoniae</italic> and <italic>Haemophilus influenza</italic></article-title><source>J Clin Epidemiol</source><year>2013</year><volume>66</volume><issue>1</issue><fpage>44</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2012.01.011</pub-id><pub-id pub-id-type="pmid">22542022</pub-id></element-citation></ref><ref id="CR52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>K</given-names></name></person-group><article-title>In search of natural substrates and inhibitors of MDR pumps</article-title><source>J Mol Microbiol</source><year>2001</year><volume>3</volume><fpage>247</fpage><lpage>254</lpage></element-citation></ref><ref id="CR53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>K</given-names></name><name><surname>Ausubel</surname><given-names>FM</given-names></name></person-group><article-title>Prospects for plant&#x02013;derived antimicrobials</article-title><source>Nat Biotechnol</source><year>2006</year><volume>24</volume><fpage>1504</fpage><lpage>1507</lpage><pub-id pub-id-type="doi">10.1038/nbt1206-1504</pub-id><pub-id pub-id-type="pmid">17160050</pub-id></element-citation></ref><ref id="CR54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Xiang</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Su</surname><given-names>Z</given-names></name></person-group><article-title>Overview on the recent study of antimicrobial peptides: origin, functions, relative mechanisms and application</article-title><source>Peptides</source><year>2012</year><volume>37</volume><issue>2</issue><fpage>207</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1016/j.peptides.2012.07.001</pub-id><pub-id pub-id-type="pmid">22800692</pub-id></element-citation></ref><ref id="CR55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Rasco</surname><given-names>BA</given-names></name><name><surname>Jabal</surname><given-names>JM</given-names></name><name><surname>Aston</surname><given-names>DE</given-names></name><name><surname>Lin</surname><given-names>M</given-names></name><name><surname>Konkel</surname><given-names>ME</given-names></name></person-group><article-title>Investigating antibacterial effects of garlic (<italic>Allium sativum</italic>) concentrate and garlic-derived organosulfur compounds on <italic>Campylobacter</italic><italic>jejuni</italic> by using fourier transform infrared spectroscopy, Raman spectroscopy, and electron microscopy</article-title><source>Appl Environ Microbiol</source><year>2011</year><volume>77</volume><issue>15</issue><fpage>5257</fpage><lpage>5269</lpage><pub-id pub-id-type="doi">10.1128/AEM.02845-10</pub-id><pub-id pub-id-type="pmid">21642409</pub-id></element-citation></ref><ref id="CR56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machado</surname><given-names>TB</given-names></name><name><surname>Pinto</surname><given-names>AV</given-names></name><name><surname>Pinto</surname><given-names>MCFR</given-names></name><name><surname>Leal</surname><given-names>ICR</given-names></name><name><surname>Silva</surname><given-names>MG</given-names></name><name><surname>Amaral</surname><given-names>ACF</given-names></name><name><surname>Kuster</surname><given-names>RM</given-names></name><name><surname>Netto-dossantos</surname><given-names>KR</given-names></name></person-group><article-title>In-vitro activity of Brazilian medicinal plants, naturally occurring naphthoquinone and their analogues, against methicillin resistant <italic>Staphylococcus aureus</italic></article-title><source>Int J Antimicrob Agents</source><year>2003</year><volume>21</volume><issue>3</issue><fpage>279</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1016/S0924-8579(02)00349-7</pub-id><pub-id pub-id-type="pmid">12636992</pub-id></element-citation></ref><ref id="CR57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGaw</surname><given-names>LJ</given-names></name><name><surname>Lall</surname><given-names>N</given-names></name><name><surname>Meyer</surname><given-names>JJM</given-names></name><name><surname>Eloff</surname><given-names>JN</given-names></name></person-group><article-title>The potential of South African plants against <italic>Mycobacterium</italic> infections</article-title><source>J Ethnopharmacol</source><year>2008</year><volume>119</volume><issue>3</issue><fpage>482</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2008.08.022</pub-id><pub-id pub-id-type="pmid">18805475</pub-id></element-citation></ref><ref id="CR58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Memish</surname><given-names>ZA</given-names></name><name><surname>Venkatesh</surname><given-names>S</given-names></name><name><surname>Shibi</surname><given-names>AM</given-names></name></person-group><article-title>Impact of travel on international spread of antimicrobial resistance</article-title><source>Int J Antimicrob Agents</source><year>2003</year><volume>21</volume><issue>2</issue><fpage>135</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1016/S0924-8579(02)00363-1</pub-id><pub-id pub-id-type="pmid">12615377</pub-id></element-citation></ref><ref id="CR59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moneim</surname><given-names>A</given-names></name><name><surname>Suleman</surname><given-names>E</given-names></name><name><surname>Issa</surname><given-names>FM</given-names></name><name><surname>Elkhalifa</surname><given-names>EA</given-names></name></person-group><article-title>Quantitative determination of tannin content in some sorghum cultivars and evaluation of its antimicrobial activity</article-title><source>Res J Microbiol</source><year>2007</year><volume>2</volume><issue>3</issue><fpage>284</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.3923/jm.2007.284.288</pub-id></element-citation></ref><ref id="CR60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norrby</surname><given-names>RS</given-names></name><name><surname>Nord</surname><given-names>CE</given-names></name><name><surname>Finch</surname><given-names>R</given-names></name></person-group><article-title>Lack of development of new antimicrobial drugs: a potential serious threat to public health</article-title><source>Lancet Infect Dis</source><year>2005</year><volume>5</volume><issue>2</issue><fpage>115</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(05)70086-4</pub-id><pub-id pub-id-type="pmid">15680781</pub-id></element-citation></ref><ref id="CR61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okeke</surname><given-names>IN</given-names></name><name><surname>Laxminarayan</surname><given-names>R</given-names></name><name><surname>Bhutta</surname><given-names>ZA</given-names></name><name><surname>Duse</surname><given-names>AG</given-names></name><name><surname>Jenkins</surname><given-names>P</given-names></name><name><surname>O&#x02019;Brien</surname><given-names>TF</given-names></name><name><surname>Pablos-Mendez</surname><given-names>A</given-names></name><name><surname>Klugman</surname><given-names>KP</given-names></name></person-group><article-title>Antimicrobial resistance in developing countries. Part I: recent trends and current status</article-title><source>Lancet Infect Dis</source><year>2005</year><volume>5</volume><issue>8</issue><fpage>481</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(05)70189-4</pub-id><pub-id pub-id-type="pmid">16048717</pub-id></element-citation></ref><ref id="CR62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okeke</surname><given-names>IN</given-names></name><name><surname>Klugman</surname><given-names>KP</given-names></name><name><surname>Bhutta</surname><given-names>ZA</given-names></name><name><surname>Duse</surname><given-names>AG</given-names></name><name><surname>Jenkins</surname><given-names>P</given-names></name><name><surname>O&#x02019;Brien</surname><given-names>TF</given-names></name><name><surname>Pablos-Mendez</surname><given-names>A</given-names></name><name><surname>Laxminarayan</surname><given-names>R</given-names></name></person-group><article-title>Antimicrobial resistance in developing countries. Part II: strategies for containment</article-title><source>Lancet Infect Dis</source><year>2005</year><volume>5</volume><issue>9</issue><fpage>568</fpage><lpage>580</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(05)70217-6</pub-id><pub-id pub-id-type="pmid">16122680</pub-id></element-citation></ref><ref id="CR63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okuma</surname><given-names>K</given-names></name><name><surname>Iwakawa</surname><given-names>K</given-names></name><name><surname>Turnidge</surname><given-names>JD</given-names></name><name><surname>Grubb</surname><given-names>WB</given-names></name><name><surname>Bell</surname><given-names>JM</given-names></name><name><surname>O&#x02019;Brien</surname><given-names>FG</given-names></name><name><surname>Coombs</surname><given-names>GW</given-names></name><name><surname>Pearman</surname><given-names>JW</given-names></name><name><surname>Tenover</surname><given-names>FC</given-names></name><name><surname>Kapi</surname><given-names>M</given-names></name><name><surname>Tiensasitorn</surname><given-names>C</given-names></name><name><surname>Ito</surname><given-names>T</given-names></name><name><surname>Hiramatsu</surname><given-names>K</given-names></name></person-group><article-title>Dissemination of new methicillin resistant <italic>Staphylococcus</italic><italic>aureus</italic> clones in the community</article-title><source>J Clin Microbiol</source><year>2002</year><volume>40</volume><issue>11</issue><fpage>4289</fpage><lpage>4294</lpage><pub-id pub-id-type="doi">10.1128/JCM.40.11.4289-4294.2002</pub-id><pub-id pub-id-type="pmid">12409412</pub-id></element-citation></ref><ref id="CR64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x000d6;z&#x000e7;elik</surname><given-names>B</given-names></name><name><surname>Deliorman</surname><given-names>OD</given-names></name><name><surname>&#x000d6;zgen</surname><given-names>S</given-names></name><name><surname>Ergun</surname><given-names>F</given-names></name></person-group><article-title>Antimicrobial activity of flavonoids against Extended Spectrum &#x003b2;-Lactamase (ESBL) producing <italic>Klebsiella</italic><italic>pneumoniae</italic></article-title><source>Trop J Pharma Res</source><year>2008</year><volume>7</volume><issue>4</issue><fpage>1151</fpage><lpage>1157</lpage><pub-id pub-id-type="doi">10.4314/tjpr.v7i4.14701</pub-id></element-citation></ref><ref id="CR65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palaniappan</surname><given-names>K</given-names></name><name><surname>Holley</surname><given-names>RA</given-names></name></person-group><article-title>Use of natural antimicrobials to increase antibiotic susceptibility of drug resistant bacteria</article-title><source>Int J Food Microbiol</source><year>2010</year><volume>140</volume><issue>2&#x02013;3</issue><fpage>164</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2010.04.001</pub-id><pub-id pub-id-type="pmid">20457472</pub-id></element-citation></ref><ref id="CR66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patino</surname><given-names>OJ</given-names></name><name><surname>Cuca</surname><given-names>LE</given-names></name></person-group><article-title>Monophyllidin, a new alkaloid <sc>l</sc>-Proline derivative from <italic>Zanthoxylum</italic><italic>monophyllum</italic></article-title><source>Phytochem Let</source><year>2011</year><volume>4</volume><fpage>22</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.phytol.2010.10.002</pub-id></element-citation></ref><ref id="CR67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ragasa</surname><given-names>CY</given-names></name><name><surname>Ha</surname><given-names>HKP</given-names></name><name><surname>Hasika</surname><given-names>M</given-names></name><name><surname>Maridable</surname><given-names>J</given-names></name><name><surname>Gaspillo</surname><given-names>P</given-names></name><name><surname>Rideout</surname><given-names>J</given-names></name></person-group><article-title>Antimicrobial and cytotoxic terpenoids from <italic>Cymbopogon citratus</italic> Stapf</article-title><source>Phillipin Sci</source><year>2008</year><volume>45</volume><issue>1</issue><fpage>111</fpage><lpage>122</lpage></element-citation></ref><ref id="CR68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajpara</surname><given-names>N</given-names></name><name><surname>Patel</surname><given-names>A</given-names></name><name><surname>Tiwari</surname><given-names>N</given-names></name><name><surname>Bahuguna</surname><given-names>J</given-names></name><name><surname>Antony</surname><given-names>A</given-names></name><name><surname>Choudhury</surname><given-names>I</given-names></name><name><surname>Ghosh</surname><given-names>A</given-names></name><name><surname>Jain</surname><given-names>R</given-names></name><name><surname>Bhardwaj</surname><given-names>AK</given-names></name></person-group><article-title>Mechanism of drug resistance in a clinical isolate of <italic>Vibrio fluvialis</italic>: involvement of multiple plasmids and integrons</article-title><source>Int J Antimicrob Agents</source><year>2009</year><volume>34</volume><fpage>220</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2009.03.020</pub-id><pub-id pub-id-type="pmid">19427174</pub-id></element-citation></ref><ref id="CR69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ram</surname><given-names>AJM</given-names></name><name><surname>Bhakshu</surname><given-names>L</given-names></name><name><surname>Raju</surname><given-names>RRV</given-names></name></person-group><article-title>In vitro antimicrobial activity of certain medicinal plants from Eastern Ghats, India, used for skin diseases</article-title><source>J Ethnopharmacol</source><year>2004</year><volume>90</volume><issue>2&#x02013;3</issue><fpage>353</fpage><lpage>357</lpage><pub-id pub-id-type="pmid">15013201</pub-id></element-citation></ref><ref id="CR70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renisheya</surname><given-names>JJMT</given-names></name><name><surname>Johnson</surname><given-names>M</given-names></name><name><surname>Mary</surname><given-names>MU</given-names></name><name><surname>Arthy</surname><given-names>A</given-names></name></person-group><article-title>Antimicrobial activity of ethanolic extracts of selected medicinal plants against human pathogens</article-title><source>Asian Pac J Trop Biomed</source><year>2011</year><volume>1</volume><issue>1</issue><fpage>S76</fpage><lpage>S78</lpage><pub-id pub-id-type="doi">10.1016/S2221-1691(11)60128-7</pub-id></element-citation></ref><ref id="CR71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riordan</surname><given-names>JT</given-names></name><name><surname>O&#x02019;Leary</surname><given-names>JO</given-names></name><name><surname>Gustafson</surname><given-names>JE</given-names></name></person-group><article-title>Contribution of SigB and SarA to distinct multiple antimicrobial resistance mechanisms of <italic>Staphylococcus aureus</italic></article-title><source>Int J Antimicrob Agents</source><year>2006</year><volume>28</volume><issue>1</issue><fpage>54</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2006.01.013</pub-id><pub-id pub-id-type="pmid">16777384</pub-id></element-citation></ref><ref id="CR72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>MC</given-names></name></person-group><article-title>Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution</article-title><source>FEMS Microbiol Rev</source><year>1996</year><volume>19</volume><fpage>1</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6976.1996.tb00251.x</pub-id><pub-id pub-id-type="pmid">8916553</pub-id></element-citation></ref><ref id="CR73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahu</surname><given-names>MC</given-names></name><name><surname>Padhy</surname><given-names>RN</given-names></name></person-group><article-title>In vitro antimicrobial potency of <italic>Butea monosperma</italic> Lam. against 12 clinically isolated multidrug resistant bacteria</article-title><source>Asia Pac J Trop Disease</source><year>2013</year><volume>3</volume><issue>3</issue><fpage>217</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1016/S2222-1808(13)60044-4</pub-id></element-citation></ref><ref id="CR74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savage</surname><given-names>PB</given-names></name></person-group><article-title>Multidrug resistant bacteria: overcoming antibiotic permeability barriers of Gram-negative bacteria</article-title><source>Ann Med</source><year>2001</year><volume>33</volume><fpage>167</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.3109/07853890109002073</pub-id><pub-id pub-id-type="pmid">11370769</pub-id></element-citation></ref><ref id="CR75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlegelova</surname><given-names>J</given-names></name><name><surname>Vlkova</surname><given-names>H</given-names></name><name><surname>Babak</surname><given-names>V</given-names></name><name><surname>Holasova</surname><given-names>M</given-names></name><name><surname>Jaglic</surname><given-names>Z</given-names></name></person-group><article-title>Resistance to erythromycin of <italic>Staphylococcus</italic> spp. isolates from the food chain</article-title><source>Veterinarni Med</source><year>2008</year><volume>53</volume><issue>6</issue><fpage>307</fpage><lpage>314</lpage></element-citation></ref><ref id="CR76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semwal</surname><given-names>DK</given-names></name><name><surname>Rawat</surname><given-names>U</given-names></name></person-group><article-title>Antimicrobial hasubanalactam alkaloid from <italic>Stephania glabra</italic></article-title><source>Planta Med</source><year>2009</year><volume>75</volume><issue>4</issue><fpage>378</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1055/s-0028-1112223</pub-id><pub-id pub-id-type="pmid">19148860</pub-id></element-citation></ref><ref id="CR77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soge</surname><given-names>OO</given-names></name><name><surname>Adeniyi</surname><given-names>BA</given-names></name><name><surname>Roberts</surname><given-names>MC</given-names></name></person-group><article-title>New antibiotic resistance genes associated with CTX-M plasmids from uropathogenic Nigerian <italic>Klebsiella</italic><italic>pneumoniae</italic></article-title><source>J Antimicrob Chemother</source><year>2006</year><volume>58</volume><fpage>1048</fpage><lpage>1053</lpage><pub-id pub-id-type="doi">10.1093/jac/dkl370</pub-id><pub-id pub-id-type="pmid">16997844</pub-id></element-citation></ref><ref id="CR78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>J</given-names></name><name><surname>Chandra</surname><given-names>H</given-names></name><name><surname>Singh</surname><given-names>N</given-names></name></person-group><article-title>Allelopathic response of <italic>Vetiveria</italic><italic>zizanioides</italic> (L.) Nash on members of the family Enterobacteriaceae and <italic>Pseudomonas</italic> spp</article-title><source>Environmentalist</source><year>2007</year><volume>27</volume><fpage>253</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.1007/s10669-007-9002-2</pub-id></element-citation></ref><ref id="CR79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stermitz</surname><given-names>FR</given-names></name><name><surname>Lorenz</surname><given-names>P</given-names></name><name><surname>Tawara</surname><given-names>JN</given-names></name><name><surname>Zenewicz</surname><given-names>LA</given-names></name><name><surname>Lewis</surname><given-names>K</given-names></name></person-group><article-title>Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5&#x02032;-methoxyhydnocarpin, a multidrug pump inhibitor</article-title><source>Appl Biol Sci</source><year>2000</year><volume>97</volume><issue>4</issue><fpage>1433</fpage><lpage>1437</lpage></element-citation></ref><ref id="CR80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Styers</surname><given-names>D</given-names></name><name><surname>Sheehan</surname><given-names>DJ</given-names></name><name><surname>Hogan</surname><given-names>P</given-names></name><name><surname>Sahm</surname><given-names>DF</given-names></name></person-group><article-title>Laboratory-based surveillance of current antimicrobial resistance patterns and trends among <italic>Staphylococcus aureus</italic>: 2005 status in the United States</article-title><source>Ann Clin Microb Antimicrob</source><year>2006</year><volume>5</volume><fpage>2</fpage><pub-id pub-id-type="doi">10.1186/1476-0711-5-2</pub-id></element-citation></ref><ref id="CR81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tegos</surname><given-names>G</given-names></name><name><surname>Stremitz</surname><given-names>FR</given-names></name><name><surname>Lomovskaya</surname><given-names>O</given-names></name><name><surname>Lewis</surname><given-names>K</given-names></name></person-group><article-title>Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials</article-title><source>Antimicrob Agents Chemother</source><year>2002</year><volume>46</volume><issue>10</issue><fpage>3133</fpage><lpage>3141</lpage><pub-id pub-id-type="doi">10.1128/AAC.46.10.3133-3141.2002</pub-id><pub-id pub-id-type="pmid">12234835</pub-id></element-citation></ref><ref id="CR82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tekwu</surname><given-names>EM</given-names></name><name><surname>Pieme</surname><given-names>AC</given-names></name><name><surname>Beng</surname><given-names>VP</given-names></name></person-group><article-title>Investigations of antimicrobial activity of some Cameroonian medicinal plant extracts against bacteria and yeast with gastrointestinal relevance</article-title><source>J Ethnopharmacol</source><year>2012</year><volume>142</volume><issue>1</issue><fpage>265</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2012.05.005</pub-id><pub-id pub-id-type="pmid">22583961</pub-id></element-citation></ref><ref id="CR83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomma</surname><given-names>BPHT</given-names></name><name><surname>Cammue</surname><given-names>BPA</given-names></name><name><surname>Thevissen</surname><given-names>K</given-names></name></person-group><article-title>Plant defensins</article-title><source>Planta</source><year>2002</year><volume>216</volume><fpage>193</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1007/s00425-002-0902-6</pub-id><pub-id pub-id-type="pmid">12447532</pub-id></element-citation></ref><ref id="CR84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorrold</surname><given-names>CA</given-names></name><name><surname>Letsoalo</surname><given-names>ME</given-names></name><name><surname>Duse</surname><given-names>AG</given-names></name><name><surname>Marais</surname><given-names>E</given-names></name></person-group><article-title>Efflux pump activity in fluoroquinolone and tetracycline resistant <italic>Salmonella</italic> and <italic>E. coli</italic> implicated in reduced susceptibility to household antimicrobial cleaning agents</article-title><source>Int J Food Microbiol</source><year>2007</year><volume>113</volume><issue>3</issue><fpage>315</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2006.08.008</pub-id><pub-id pub-id-type="pmid">17126442</pub-id></element-citation></ref><ref id="CR85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Threlfall</surname><given-names>EJ</given-names></name></person-group><article-title>Antimicrobial drug resistance in Salmonella: problems and perspective in food and water-borne infections</article-title><source>FEMS Microbiol Rev</source><year>2002</year><volume>26</volume><issue>2</issue><fpage>141</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6976.2002.tb00606.x</pub-id><pub-id pub-id-type="pmid">12069879</pub-id></element-citation></ref><ref id="CR86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Upadhyaya</surname><given-names>S</given-names></name></person-group><article-title>Screening of phytochemicals, nutritional status, antioxidant and antimicrobial activity of <italic>Paderia foetida</italic> Linn. From different localities of Assam, India</article-title><source>J Pharm Res</source><year>2013</year><volume>7</volume><issue>1</issue><fpage>139</fpage><lpage>141</lpage></element-citation></ref><ref id="CR87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vila</surname><given-names>J</given-names></name><name><surname>Pal</surname><given-names>T</given-names></name></person-group><article-title>Update on antimicrobial resistance in low income countries: factors favouring the emergence of resistance</article-title><source>Open Infect Dis J</source><year>2010</year><volume>4</volume><fpage>38</fpage><lpage>54</lpage></element-citation></ref><ref id="CR88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname><given-names>J</given-names></name><name><surname>Wilcock</surname><given-names>A</given-names></name><name><surname>Coventry</surname><given-names>MJ</given-names></name></person-group><article-title>The effect of essential oil of basil on the growth of <italic>Aeromonas</italic><italic>hydrophila</italic> and <italic>Pseudomonas</italic><italic>fluorescens</italic></article-title><source>J Appl Microbiol</source><year>1998</year><volume>84</volume><fpage>152</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2672.1998.00338.x</pub-id><pub-id pub-id-type="pmid">9633630</pub-id></element-citation></ref><ref id="CR89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Bang</surname><given-names>JK</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>JK</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Shin</surname><given-names>SY</given-names></name></person-group><article-title>Antimicrobial specificity and mechanism of action of disulfide&#x02014;removed linear analogs of the plant derived cys-rich antimicrobial peptides Ib-AMP1</article-title><source>Peptides</source><year>2009</year><volume>30</volume><issue>12</issue><fpage>2144</fpage><lpage>2149</lpage><pub-id pub-id-type="doi">10.1016/j.peptides.2009.09.020</pub-id><pub-id pub-id-type="pmid">19778562</pub-id></element-citation></ref><ref id="CR90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warnke</surname><given-names>PH</given-names></name><name><surname>Becker</surname><given-names>ST</given-names></name><name><surname>Podschun</surname><given-names>R</given-names></name><name><surname>Sivanathan</surname><given-names>S</given-names></name><name><surname>Springer</surname><given-names>IN</given-names></name><name><surname>Russo</surname><given-names>PAI</given-names></name><name><surname>Wiltfang</surname><given-names>J</given-names></name><name><surname>Fickenscher</surname><given-names>H</given-names></name><name><surname>Sherry</surname><given-names>E</given-names></name></person-group><article-title>The battle against multi resistant strains: renaissance of antimicrobial essential oils as a promising force to fight hospital acquired infections</article-title><source>J Cranio Maxillofacial Surg</source><year>2009</year><volume>37</volume><issue>7</issue><fpage>392</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1016/j.jcms.2009.03.017</pub-id></element-citation></ref><ref id="CR91"><mixed-citation publication-type="other">WHO (World Health Organization) (2011) Combat antimicrobial resistance. <ext-link ext-link-type="uri" xlink:href="http://www.who.int/world-health-day/2011">http://www.who.int/world-health-day/2011</ext-link></mixed-citation></ref><ref id="CR92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Widelski</surname><given-names>J</given-names></name><name><surname>Popova</surname><given-names>M</given-names></name><name><surname>Graikou</surname><given-names>K</given-names></name><name><surname>Glowniak</surname><given-names>K</given-names></name><name><surname>Chinou</surname><given-names>I</given-names></name></person-group><article-title>Coumarins from <italic>Angelica lucida</italic> L.&#x02014;antibacterial activities</article-title><source>Molecule</source><year>2009</year><volume>14</volume><fpage>2729</fpage><lpage>2734</lpage><pub-id pub-id-type="doi">10.3390/molecules14082729</pub-id></element-citation></ref><ref id="CR93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>GD</given-names></name></person-group><article-title>Bacterial resistance to antibiotics: enzymatic degradation and modification</article-title><source>Adv Drug Deliv Rev</source><year>2005</year><volume>57</volume><issue>10</issue><fpage>1451</fpage><lpage>1470</lpage><pub-id pub-id-type="doi">10.1016/j.addr.2005.04.002</pub-id><pub-id pub-id-type="pmid">15950313</pub-id></element-citation></ref><ref id="CR94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Lewis</surname><given-names>K</given-names></name></person-group><article-title>Febatins: new antimicrobial plant peptides</article-title><source>FEMS Microbiol Lett</source><year>1997</year><volume>149</volume><fpage>59</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6968.1997.tb10308.x</pub-id><pub-id pub-id-type="pmid">9103978</pub-id></element-citation></ref></ref-list></back></article>